Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Frederick G. Freitag DO
Associate Professor
Department of Neurology
Division of General

OFFICE ADDRESS:
Froedtert West Clinics
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
1970 - 1974 B.S. Biochemistry, University of Wisconsin, Madison, Wisconsin
1970 - 1974 B.S. Biochemistry, University of Wisconsin, Madison, Wisconsin
1974 - 1975 Masters Coursework, Biochemistry, University of Wisconsin, Madison
1974 - 1975 Masters Coursework, Biochemistry, University of Wisconsin, Madison
1975 - 1979 D.O., Chicago College of Osteopathic Medicine, Chicago, Illinois
1975 - 1979 D.O., Chicago College of Osteopathic Medicine, Chicago, Illinois
07/01/1979 - 06/30/1980 AOA Approved Rotating Internship, Brentwood Hospital, Warrensville Heights, Ohio
07/01/1979 - 06/30/1980 AOA Approved Rotating Internship, Brentwood Hospital, Warrensville Heights, Ohio
01/1980 - 06/30/1981 Family Practice Resident, Brentwood Hospital, Warrensville Heights, Ohio
01/1980 - 06/30/1981 Family Practice Resident, Brentwood Hospital, Warrensville Heights, Ohio
01/02/1981 - 03/31/1981 Fellow, Section of Headache Medicine, Department of Internal Medicine, Cleveland Clinic Foundation
01/02/1981 - 03/31/1981 Fellow, Section of Headache Medicine, Department of Internal Medicine, Cleveland Clinic Foundation
POSTDOCTORAL TRAINING:
POSTDOCTORAL TRAINING:

MILITARY SERVICE:
1970 - 1971 United States Air Force
1970 - 1971 United States Air Force

FACULTY APPOINTMENTS:
1981 - 1983 Clinical Associate Professor, Department of Family Medicine, Ohio University College of Osteopathic Medicine, Athens, Ohio
1981 - 1983 Clinical Associate Professor, Department of Family Medicine, Ohio University College of Osteopathic Medicine, Athens, Ohio
1988 - 1989 Visiting Lecturer, Department of Family Medicine, Midwestern University, Chicago College of Osteopathic Medicine, Downers Grove, Illinois
1988 - 1989 Visiting Lecturer, Department of Family Medicine, Midwestern University, Chicago College of Osteopathic Medicine, Downers Grove, Illinois
1989 - 1993 Clinical Associate Professor, Department of Medicine University of Chicago, Chicago, Illinois
1989 - 1993 Clinical Associate Professor, Department of Medicine University of Chicago, Chicago, Illinois
1989 - 2010 Affiliate Instructor, Department of Family Medicine, Midwestern University, Chicago College of Osteopathic Medicine, Downers Grove, Illinois
1989 - 2010 Affiliate Instructor, Department of Family Medicine, Midwestern University, Chicago College of Osteopathic Medicine, Downers Grove, Illinois
1999 - 2012 Clinical Assistant Professor, Department of Family Medicine, Rosalind Franklin University of Medicine and Science, Chicago Medical School, North Chicago, Illinois
1999 - 2012 Clinical Assistant Professor, Department of Family Medicine, Rosalind Franklin University of Medicine and Science, Chicago Medical School, North Chicago, Illinois
2013 - Present Associate Professor, Department of Neurology Medical College of Wisconsin, Milwaukee, Wisconsin
2013 - Present Associate Professor, Department of Neurology Medical College of Wisconsin, Milwaukee, Wisconsin

ADMINISTRATIVE APPOINTMENTS:
1985 - 2009 Director of Clinical Research, Diamond Headache Clinic, Chicago, Illinois
1985 - 2009 Director of Clinical Research, Diamond Headache Clinic, Chicago, Illinois
1986 - 2008 Associate Director, Diamond Headache Clinic, Chicago, Illinois
1986 - 2008 Associate Director, Diamond Headache Clinic, Chicago, Illinois
2008 - 2010 Co-Director, Diamond Headache Clinic, Chicago, Illinois
2008 - 2010 Co-Director, Diamond Headache Clinic, Chicago, Illinois
2010 - 2013 Director of Headache Medicine Research, Baylor Research Institute, Dallas, Texas
2010 - 2013 Director of Comprehensive Headache Medicine Program. Baylor Health Care System, Dallas, Texas
2010 - 2013 Director of Headache Medicine Research, Baylor Research Institute, Dallas, Texas
2010 - 2013 Director of Comprehensive Headache Medicine Program. Baylor Health Care System
2011 - 2013 Director of UCNS Headache Medicine Fellowship Program, Baylor University Medical Center, Dallas, Texas
2011 - 2013 Director of UCNS Headache Medicine Fellowship Program, Baylor University Medical Center, Dallas, Texas
2011 - 2013 Director of UCNS Headache Medicine Fellowship Program, Baylor University Medical
2011 - 2013 Director of UCNS Headache Medicine Fellowship Program, Baylor University Medical
2013 - Present Director Headache Medicine Fellowship, Medical College of Wisconsin, Milwaukee, Wisconsin
2013 - Present Director Headache Medicine Section, Froedtert and the Medical College of Wisconsin, Department of Neurology, Milwaukee, Wisconsin
2013 - Present Director Headache Medicine Fellowship, Medical College of Wisconsin, Milwaukee
2013 - Present Director Headache Medicine Section, Froedtert and the Medical College of Wisconsin, Department of Neurology, Milwaukee, Wisconsin
Dallas, Texas
EDUCATION ADMINISTRATIVE APPOINTMENTS:
Wisconsin
Center, Dallas, Texas
EDUCATION ADMINISTRATIVE APPOINTMENTS:
Center, Dallas, Texas

RESEARCH ADMINISTRATIVE APPOINTMENTS:
2012 - 2013 Director of Headache Medicine Research, Baylor Research Institute, Dallas, Texas
2012 - 2013 Director of Headache Medicine Research, Baylor Research Institute, Dallas, Texas

HOSPITAL STAFF PRIVILEGES:
1981 - 1983 Brentwood Hospital, Warrensville Heights, Ohio
1981 - 1983 Brentwood Hospital, Warrensville Heights, Ohio
1983 - 1993 Louis A. Weiss Memorial Hospital, Chicago, Illinois
1983 - 1993 Louis A. Weiss Memorial Hospital, Chicago, Illinois
1993 - 2000 Columbus Hospital/Catholic Health Partners, Chicago, Illinois
1993 - 2000 Columbus Hospital/Catholic Health Partners, Chicago, Illinois
2000 - 2010 Saint Joseph Hospital/Resurrection Healthcare, Chicago, Illinois
2000 - 2010 Saint Joseph Hospital/Resurrection Healthcare, Chicago, Illinois
2010 - 2012 Baylor All Saints Medical Center, Ft. Worth Texas
2010 - 2012 Baylor All Saints Medical Center, Ft. Worth Texas
2010 - 2013 Baylor University Medical Center, Dallas, Texas
2010 - 2013 Baylor University Medical Center, Dallas, Texas
2013 - Present Froedtert Hospital and Clinics, Milwaukee, Wisconsin
2013 - Present Froedtert Hospital and Clinics, Milwaukee, Wisconsin
- 1386 NPI: 1386636272
DEA: AF2035714
Wisconsin: # 59956-21 2012 2018
Texas: # N6870 (inactive) 2010 2017
Illinois: # 036-066039 1983 2018
LICENSURE: ISSUE DATE EXPIRATION DATE
In Headache Management 1998 None
CAQ National Board for Certification
CERTIFICATES ISSUED BY ISSUE DATE EXPIRATION
Practitioners #1960 3/8/1982 None
American Board of Osteopathic Family
United Council for Neurologic Subspecialties
Subspecialty Certification for Headache Medicine, 10/31/2016 11/1/2027
United Council for Neurologic Subspecialties
Subspecialty Certification for Headache Medicine, 10/31/2007 11/1/2017
BOARD CERTIED ISSUE DATE EXIPIRATION
Ohio: # 34-00-3031(inactive) 1980 2017
FELLOWSHIP ISSUE DATE
SPECIALITY BOARDS AND CERTIFICATION:
American Headache Society 1993

AWARDS AND HONORS:
1988 - 2003 Who's Who in the Midwest
1988 - 2003 Who's Who in the Midwest
1988 - 1993 Who's Who of Emerging Leaders in America
1988 - 1993 Who's Who of Emerging Leaders in America
1989 - Present 1st Place, Sandoz Headache Examination, IV International Headache Congress, Sydney, Australia
1989 - Present 1st Place, Sandoz Headache Examination, IV International Headache Congress, Sydney, Australia
1990 - 1993 Who's Who Among Young American Professionals
1990 - 2012 Who's Who in the World
1990 - 1993 Who's Who Among Young American Professionals
1990 - 2012 Who's Who in the World
1995 - 2004 Who's Who in Science and Engineering
1995 - 2012 Who's Who in Medicine and Healthcare
1995 - 2012 Who's Who in Medicine and Healthcare
1995 - 2004 Who's Who in Science and Engineering
1999 - Present Who's Who in America
1999 - Present Who's Who in America
2001 - Present US News and World Reports Top Doctors in the US
2001 - Present US News and World Reports Top Doctors in the US
2002 - 2005 Guide to America's Top Physicians
2002 - 2005 Guide to America's Top Physicians
2004 - 2010 Chicago Magazine - Top Doctors
2004 - Present Castle Connelly Top Doctors
2004 - 2010 Chicago Magazine - Top Doctors
2004 - Present Castle Connelly Top Doctors
2004 - Present America's Top Doctors
2004 - Present America's Top Doctors
2015 - Present Medical College of Wisconsin: Outstanding Faculty Service Award
2015 - 2016 Milwaukee Magazine -Top Doctors
2015 - Present Medical College of Wisconsin: Outstanding Faculty Service Award
2015 - 2016 Milwaukee Magazine -Top Doctors

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1985 - 1989 Member, Pharmacy and Therapeutic Committee, Louis A. Weiss Memorial Hospital
1985 - 1989 Member, Research Committee, Louis A. Weiss Memorial Hospital
1985 - 1989 Member, Research Committee, Louis A. Weiss Memorial Hospital
1985 - 1989 Member, Pharmacy and Therapeutic Committee, Louis A. Weiss Memorial Hospital
1989 - 1991 Member, Institutional Review Board, Louis A. Weiss Memorial Hospital
1989 - 1993 Chairman, Research Committee, Louis A. Weiss Memorial Hospital
1989 - 1993 Chairman, Research Committee, Louis A. Weiss Memorial Hospital
1989 - 1991 Member, Institutional Review Board, Louis A. Weiss Memorial Hospital
1991 - 1993 Chairman, Institutional Review Board, Louis A. Weiss Memorial Hospital
1991 - 1993 Chairman, Institutional Review Board, Louis A. Weiss Memorial Hospital
2002 - 2003 Member, Institutional Review Board, Saint Joseph Hospital, Chicago, IL
2002 - 2003 Member, Institutional Review Board, Saint Joseph Hospital, Chicago, IL
2004 - 2005 Member, Pharmacy and Therapeutics Committee, Saint Joseph Hospital, Chicago, IL
2004 - 2005 Member, Pharmacy and Therapeutics Committee, Saint Joseph Hospital, Chicago, IL
2008 - 2009 Member, Ethics Committee, Saint Joseph Hospital, Chicago, IL
2008 - 2009 Member, Ethics Committee, Saint Joseph Hospital, Chicago, IL

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1985 - Present American Medical Association Work Group 5: Evaluation Assessment and Control
1985 - Present American Medical Association Work Group 5: Evaluation Assessment and Control
1986 - 1988 Agency for Health Care Policy Research, Panel Member
1986 - 1988 Membership Committee, American Headache Society
1986 - 1988 Agency for Health Care Policy Research, Panel Member
1988 - 1992 Member, Practice Ad Hoc Committee, American Headache Society
1992 - 1994 Member, Constitution and Bylaws Committee, American Headache Society
1993 - 2009 Member Research Committee, National Headache Foundation
1993 - 2009 Member Research Committee, National Headache Foundation
1993 - 2012 Member of Board of Director, National Headache Foundation
1993 - 2012 Member of Board of Director, National Headache Foundation
1994 - 2007 Chair, Fellowship Committee, National Headache Foundation
1994 - 2007 Chair, Fellowship Committee, National Headache Foundation
1995 - 2008 Member, Newsletter Committee, National Headache Foundation
1995 - 2004 Member, Therapeutic Guide Committee, National Headache Foundation
1995 - 2004 Member, Therapeutic Guide Committee, National Headache Foundation
1995 - 2008 Member, Newsletter Committee, National Headache Foundation
1996 - 1997 American Society for Clinical Pharmacology and Therapeutics, Vice Chairman, Section on Headache
1996 - 1997 American Society for Clinical Pharmacology and Therapeutics, Vice Chairman, Section on Headache
1998 - 2007 Chair, Administrative Committee, National Board for Certification in Headache Management
1998 - 2007 Member, Board of Directors, National Board for Certification in Headache Management
1998 - 2012 U.S. Headache Guideline Consortium, Preventative Section Member
1998 - 2010 Diamond Headache Research and Education Foundation Research and Educational Foundation, Associate Course Director
1998 - 2007 Member, Board of Directors, National Board for Certification in Headache Management
1998 - 2010 Diamond Headache Research and Education Foundation Research and Educational Foundation, Associate Course Director
1998 - 2012 U.S. Headache Guideline Consortium, Preventative Section Member
1998 - 2007 Chair, Administrative Committee, National Board for Certification in Headache Management
1999 - 2002 Secretary/Treasurer, National Board for Certification in Headache Management
1999 - 2002 Secretary/Treasurer, National Board for Certification in Headache Management
1999 - 2002 Chair, Communication Committee, National Headache Foundation
1999 - 2002 Chair, Communication Committee, National Headache Foundation
2000 - 2006 American Osteopathic Association. Chairperson, American Osteopathic Association Headache Council, a sub group of AOA Women's Health Advisory Committee
2000 - 2002 Chairperson, Primary Care Special Interest Section, American Headache Society
2000 - 2006 American Osteopathic Association. Chairperson, American Osteopathic Association Headache Council, a sub group of AOA Women's Health Advisory Committee
2002 - 2007 Vice President, National Board for Certification in Headache Management
2002 - 2004 2012- 2014 Member, Education Committee, American Headache Society
2002 - 2007 Vice President, National Board for Certification in Headache Management
2002 - 2003 Chairperson, Primary Care Education Initiation, American Headache Society
2003 - 2005 Chair, Vision Committee, National Headache Foundation
2003 - 2005 Chair, Vision Committee, National Headache Foundation
2006 - 2008 Practice Committee, American Headache Society
2009 - 2012 Chair, Research and Bio-Medical Education Committee, National Headache Foundation
2009 - 2012 Chair, Research and Bio-Medical Education Committee, National Headache Foundation
2010 - 2011 Vice-President Board of Directors, National Headache Foundation
2010 - 2011 Vice-President Board of Directors, National Headache Foundation
2011 - 2012 National Institutes of Health, National Institute of Neurological Disorders and Stroke, Headache Common Data Elements Working Group
2011 - 2012 National Institutes of Health, National Institute of Neurological Disorders and Stroke, Headache Common Data Elements Working Group
2012 - Present AHRQ Effective Health Care Peer Reviewer
2012 - Present AHRQ Effective Health Care Peer Reviewer
Member, Constitution and Bylaws Committee, 1992 - 1994 American Headache Society
Member, Practice Ad Hoc Committee, 1988 - 1992 American Headache Society
Membership Committee, 1986 - 1988 American Headache Society
Practice Committee, 2006 - 2008 American Headache Society
Alternate Delegate, Health Policy Agenda for the American People
Member, Education Committee, 2002 - 2004, 2012- 2014 American Headache Society
Chairperson, Primary Care Special Interest Section, 2000 - 2002 American Headache Society
Chairperson, Primary Care Education Initiation, 2002 - 2003 American Headache Society
Alternate Delegate, Health Policy Agenda for the American People

INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1986 - 1989 Janssen Research Council, Member
1994 - Present International Association for the Study of Pain, Member, Host Committee
2011 - Present Migraine Research Foundation, Medical Advisory Committee
Creighton University Medical Center, Lecture: Migraine. Omaha, Nebraska, May 15-16, 1997.
V.A. Medical Center, Lecture: Migraine. Los Angeles, California, May 8-9, 1997
Long Island College Hospital, Lecture: Migraine. Brooklyn, New York, December 4, 1997.
Virginia Medical Center, Lecture: New Treatment in Migraine Prevention. Hampton, Virginia, October 21, 1997.
University of Wisconsin Hospital, Lecture: Migraine. Madison, Wisconsin, September 12, 1997
University of California San Diego Medical Center, Lecture: Migraine. San Diego, California, December 5, 1997.
Chicago Medical Society 1999 Midwest Clinical Conference, Headache Update, Lectures: Cluster Headaches: Diagnosis and Treatment, Inpatient Treatment of Headache. Chicago, Illinois, February 26-28, 1999.
University of Texas at San Antonio, Clinical Neurology Update, CME Program: Women and Headache. San Antonio, Texas, November 18, 1999
Chicago Medical Society, Midwest Medical Conference 2001, CME Lecture: Cluster Headache Issues - Headache Update on Newer Treatments, Navy Pier, Chicago, February 25, 2001.
103rd Ohio Osteopathic Convention, Ohio Osteopathic Association, Headaches and Hormones, Columbus, Ohio, June 28, 2001
Michigan State University College of Osteopathic Medicine, OB/GYNE Educational Conference, Lectures: Approach to Headaches: Migraine Cephalalgia; Menstrual-Related Migraines; Approach to Headaches in Pregnancy. November 15, 2001.
Annual Mid-Year Conference, Kansas Association of Osteopathic Medicine, Topeka, Kansas, CME Lecture: Changing Approaches in Migraine Diagnosis & Management, November 10, 2001.
Texas Osteopathic Medical Association, 46th Mid-Winter Conference and Legislative Symposium, Lecture: Management of Migraine Headaches in the Primary Care Practice. Dallas, Texas, February 9, 2002.
Indiana Osteopathic Association, 105th Annual Convention, Lecture: Headache Update, Indianapolis, Indiana, May 3, 2002.
Oklahoma Osteopathic Association, 102nd Annual Convention, Lecture: Current Approaches in the Management of Migraine Headaches. Oklahoma City, Oklahoma, April 26, 2002.
Pinnacle Health Systems, Lecture: Management of the Headache Patient in the Primary Care Setting, Harrisburg, Pennsylvania, June 28, 2002
Postgraduate Institute for Medicine, Houston Women's Health Update, Lecture: Managing Headaches in Women: Recent Advances in New Treatment Approaches, Houston, Texas, November 14, 2002.
Florida State University Department of Neurology Alumni Lecture: New Treatment Options for the Prevention of Migraine, Gainesville, Florida, October 24-25, 2002.
University of Florida College of Medicine, Lecture: Management of Chronic Pain, Jacksonville, Florida, October 23, 2002.
Meridia Southpoint Hospital, Grand Rounds Lecture: Current Concepts on Acute Migraine Management, Cleveland, Ohio, May 9, 2003.
Chicago Medical Society Midwest Clinical Conference 2003, Lecture: A Review of the New and Old Agents in Headache Prophylaxis, Chicago, Illinois, March 22, 2003.
Chicago Medical Society Midwest Clinical Conference 2004, Lecture: Detoxification in the Headache Patient, Chicago, Illinois, March 27, 2004.
Washington University, Grand Rounds Lecture Neurology: Approach to Acute Migraine Management, St. Louis, Missouri, March 1, 2004
University of South Florida College of Medicine, Headache and Pain, Fall Symposium CME Lecture: Inpatient Headache Management, Tampa, Florida, November 5, 2004.
Partners Community Health Care, CME Lecture: Considerations for Effective Migraine Management, Boston, Massachusetts, September 29, 2004.
Saint Joseph Hospital, CME Grand Rounds Lecture: Clinical Management of Migraine, Chicago, Illinois, November 10, 2004.
Swedish Covenant Hospital, CME Grand Rounds Lecture: Management of Frequent Migraines, Chicago, Illinois, November 10, 2004.
Northern Physician's Assistants Association, CME Lecture: Migraine Diagnosis and Stratification, Lincolnshire, Illinois, November 9, 2004.
Rockford Memorial Hospital, CME Lecture: Chronic Migraine: Factors in its Evolution and Therapeutic Strategies, Rockford, Illinois, October 26, 2005
West Suburban Hospital, CME Grand Rounds Lecture: Migraine Headache and the Different Options, Oak Park, Illinois, December 15, 2005.
Saint Francis Medical Center, CME Grand Rounds Lecture: Pharmacokinetic and Neuronal Mechanisms Influencing Acute Migraine Treatment, Peoria, Illinois, October 19-20, 2006.
Creighton University Department of Neurology. Lecture: When Other Migraine Medications Stop Short, Omaha, Nebraska, October 24, 2008.
Illinois Osteopathic Medical Society Winter Scientific Seminar, Lecture Migraines/Pediatric Headache, Lombard, Illinois, December 4, 2008.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture Inpatient Treatment of Headache, Chicago, Illinois, November 22, 2008.
62nd Annual Ward E. Perrin Clinical Refresher Course, Migraine Management for the Primary Care Office, Oak Brook, Illinois, October 22, 2009
Scripps, Headaches: Easing the Pain Conference, Lecture (1) High Yield Headache Assessment Strategies for Identifying Primary vs. Secondary Headache. Lecture (2) Rescue Protocols for Acute Headache, San Diego, 2010.
Illinois Osteopath Medical Society, 2010 Scientific Seminar, Lecture (1) Headache Update: Migraine Treatments. Lecture (2) General Approach to the Headache Patient. Oak Brook, Illinois, December 3, 2010.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture (1) Cluster Headache. Lecture (2): Inpatient Treatment of Headache, Chicago, Illinois, July 12-16, 2010.
2th Annual Neuroscience Symposium Update, Irving, Texas, Migraine and Migraine Management, September 23, 2011
University of Wisconsin, Department of Neurology, Madison, Wisconsin. Grand Rounds: Neurologic Complications related to Migraine. June 10, 2011.
Baylor University Medical Center, Department of Internal Medicine, Baylor University Medical Center, Dallas, Texas. Grand Rounds: Co-Morbidities of Migraine. March 3, 2011.
Course Director, Headache Awareness 2011, Baylor Health Care System, Dallas, Texas, September 17, 2011
Lincoln Park Hospital, CME Grand Rounds Lecture: Migraine: New Diagnosis and Treatment Strategies, Chicago, Illinois, December 8, 2005
The Chicago Medical Society (CMS) 2006 Annual Midwest Clinical Conference, Lecture: Strategies for Outpatient & Inpatient Treatment of Headache Chicago, Illinois, March 22, 2006.
13th Annual Neuroscience Update. Irving, Texas. Chronic Daily Headache. September 28, 2012.
Medical College of Wisconsin Department of Neurology and Froedtert Memorial Hospital, Milwaukee Wisconsin: Grand Rounds Visiting Lecturer: Thunderclap Headache. May 31, 2012
The 28th Annual Update in Primary Care. Door County, Wisconsin. Challenges in Migraine Management in Medicine. October 10, 2015
Wisconsin Neurological Society (WNS) Annual Conference 2016, Sheboygan, Wisconsin. CGRP in Headache and Its Treatment. Oct 22, 2016.
Wisconsin Association of Osteopathic Physicians Fall CME Course. Madison, Wisconsin. Headache Treatment Issues in General Medicine. October 22, 2016
Course Director, Department of Neurology, "Contemporary Neurological Challenges in Community Practice: A Practical Approach", Milwaukee, Wisconsin January 14, 2017.
Building Partnerships: Autonomic Disorders Workshop Part II. Milwaukee, Wisconsin. When to Worry, When to Refer: Headache. Headache Management. June 2, 2017
PEER REVIEWED WORSKOPS/PRESENTATIONS:
INTERNATIONAL:
American Association for the Study of Headache, 27th Annual Meeting, Lectures: Application of Cold as Adjunctive Therapy in the Treatment of Headache, Inpatient Treatment of Headache: Long-term Results. New York, New York, June 14, 1985
American Association for the Study of Headache 28th Annual Meeting, Lecture: The Use of MAO Inhibitors and Tricyclic Antidepressants in the Treatment of Migraine and Mixed Headaches. Chicago, Illinois, June 18, 1986.
6th International Migraine Symposium, British Migraine Trust, Lecture: MAO Inhibitors and Tricyclic Antidepressants in the Treatment of Migraine. October 16, 1986.
American Association for the Study of Headache, 19th Annual Meeting, Lecture: Drug Abuse and Headache. Quebec City, Quebec, Canada, June 21, 1987.
American Association for the Study of Headache, 30th Annual Meeting, Lecture: Impact of Inpatient Headache Treatment on Subsequent Medical Care. San Francisco, California, June 18, 1988.
7th Migraine Trust International Symposium, Lecture: Monoamine Oxidase Inhibitors in Refractory Headache Patients Long-Term Experience. London, England, September, 1988.
SCIENTIFIC SOCIETIES:
American Academy of Neurology
American Headache Society
American College of Osteopathic Family Practitioners
American Osteopathic Association
International Headache Society
National Headache Foundation
Society for Pain Practice Management
Wisconsin Association of Osteopathic Physicians and Surgeons
INVITED LECTURES/WORKSHOPS/PRSENTATIONS:
INTERNATIONAL
Laboratories Dr. Esteve, S.A., International Symposium, New Aspects of the Pathophysiology of Migraine and Its Preventive Treatment, Lecture: Prophylactic Treatment of Migraine with Flunarizine. Malaga, Spain, Novem, 1984
Workshop: Study of Opioid Peptides in Biological Fluids, Lecture: Plasma and CSF Met-Enkephalin Changes in Migraine and Cluster Headache. Modena, Italy, November 28, 1987
European Aspirin Foundation, Lecture: Role of Aspirin in Headache, Aspirin Toward 2000. Brussels, Belgium, May 3, 1989.
IBC's 2nd International Conference on Migraine, Lecture: DHE: Rediscovery and Advances. Philadelphia, Pennsylvania, April 7, 1998
Chair, National Headache Foundation's 5th Annual Headache Research Summit, Plenary Sessions, Scottsdale, Arizona, February 19, 2008
National Headache Foundation 6th Headache Research Summit, Lecture Therapeutic Approaches to Progression, Bethesda, Maryland, October 30, 2008.
NATIONAL:
American College of General Practice Annual Meeting, Lecture: Headache Update and Video Patient Presentations. Orlando, Florida, July 31, 1987.
American Society of Clinical Pharmacology and Therapeutics, 89th Annual Meeting, Symposium: Dependency in the Headache Patient. Lecture: Management of the Headache Patient with Dependency Problems. San Diego, California, March 10, 1988.
Society for Pain Practice Management, 2nd Annual Meeting, Moderator: The Pain Clinic - Clinical Update. Lecture: Management of Migraine & Cluster Headache. February 11, 1990.
IV International Headache Congress, Lecture: Analgesic Efficacy and Safety of Transnasal Butorphanol (TNB) in the Acute Treatment of Migraine. Sydney, Australia, October 18, 1989.
New Insights into the Treatment of Cerebrovascular Disease, Lecture: Nimodipine in the Treatment of Headache. South Hampton, Bermuda, June 25, 1989.
American Association for the Study of Headache, 31st Annual Scientific Meeting, Lecture: Tiospirone in the Treatment of Cluster Headache. Boston, Massachusetts, June 16, 1989.
American Society of Clinical Pharmacology and Therapeutics, 92nd Annual Meeting, Symposium: Neurobiologic Mechanisms as an Approach to the Pharmacology of Headache. Lecture: Clinical Applications of the Neurobiology of Headache. San Antonio, Texas, March 15, 1991.
American Society of Clinical Pharmacology & Therapeutics, 92nd Annual Meeting, Symposium: Neurobiologic Mechanisms as an Approach to the Pharmacology of Headache. San Antonio, Texas, March 15, 1991.
First Symposium for the Treatment of Headache, Centro Especializado en Dolor de Cabeza y Neurologia, Lecture: The Interdisciplinary Approach to the Management of Headache and New Treatment Modalities. San Juan, Puerto Rico, August 23, 1997.
41st Annual Scientific Meeting, The American Association for the Study of Headache. Platform Presentation: A Comparative Study of Midrin And Sumatriptan Succinate in The Treatment of Migraine Headache. Boston, Massachusetts, June 1, 1999.
42nd Annual Scientific Meeting of the American Headache Society (AHS), Scientific Paper Session: Clinical Management, Montreal, Quebec, Canada, June 23-25, 2000.
National Institutes of Health, 21st Century Prevention and Management of Migraine Headache, Presentation: Prevention: Older Drugs (Strengths and Weaknesses). June 7-9, 2000.
American Academy of Neurology, Platform Presentation: Depakote ER in the Prophylaxis of Migraine, San Diego, California, May 1, 2000.
American Headache Society, Headache Now/Bal Harbour 2001, Primary Care: Approach to the Headache Patient. The Name Game: Headache Guidelines for Primary Care, Bal Harbour, Florida, January 19-21, 2001.
Diamond Headache Research and Education Foundation: The 3rd Annual Practicing Physician's Approach to the Difficult Headache Patient, Lectures: Complicated Migraine and Migraine Variants, Emergency Room Treatment of the Headache Patient. Palm Springs, California, February 21-24, 1990.
American College of General Practitioners in Osteopathic Medicine and Surgery, Lecture: Pediatric and Adolescent Headache Syndromes. Washington, D.C., March 9, 1991
Diamond Headache Research and Education Foundation: The 4th Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture: Complicated Migraine and Migraine Variants, Palm Springs, California, February 20-23, 1991.
Diamond Headache Research and Education Foundation: The 5th Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture: Drug Abuse in the Headache Patient. Palm Springs, California, February 19-22, 1992.
Society of Pain Practice Management, Lectures: Muscle Contraction (Tension-Type) Headache, Migraine Headache. Chicago, Illinois, September 27, 1992.
American Academy of Pain Management, 1992 Conference, Lecture: New Approaches for Control of Head Pain. Albuquerque, New Mexico, October 10, 1992.
Diamond Headache Research and Education Foundation: The 6th Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture: Inpatient Care of the Headache Patient. Palm Springs, California, February 27, 1993.
Diamond Headache Research and Education Foundation: Headache Update 1993, Lectures: Inpatient Care of the Headache Patient, and Complicated Migraine and Migraine Variants. Orlando, Florida, August 1993.
American Association of Osteopathic Specialists, 41st Annual Meeting, Pain Management, Lecture: Headache. New Orleans, Louisiana, June 13-16, 1993.
Diamond Headache Research and Education Foundation: The 7th Annual the Practicing Physician's Approach to the Difficult Headache Patient, Lectures: Complicated Migraine and Migraine Variants and Inpatient Care of the Headache Patient. Palm Springs, California, February 23-27, 1994
Diamond Headache Research and Education Foundation: Headache Update 1994, Lecture: Inpatient Treatment of the Difficult Headache Patient. Orlando, Florida, August 4-7, 1994.
Diamond Headache Research and Education Foundation: Headache Update 1995, Lecture: Inpatient Treatment of the Headache Patient. Orlando, Florida, August 3-6, 1995.
Diamond Headache Research and Education Foundation: The 9th Annual Practicing Physician's Approach to the Difficult Headache Patient, Lectures: Conducting Clinical Research at an Outpatient Headache Clinic and Inpatient Care of the Headache Patient. Palm Springs, California, February 14-18, 1996.
Diamond Headache Research and Education Foundation: Headache Update 1996, Lecture: Inpatient Care of the Headache Patient. Orlando, Florida, July 18-21, 1996.
Diamond Headache Research and Education Foundation: The 10th Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture (1): Cluster Headache. Lecture (2) Cluster Headache and Cranial Neuralgias. Lecture (3) Inpatient Care of the Headache Patient. Palm Springs, California, February 18-22, 1997.
Intensive Update in Family Medicine, American College of Osteopathic Family Physicians, Lecture: Headache and Migraines. Rosemont, Illinois, August 13-16, 1997.
Diamond Headache Research and Education Foundation: Headache Update 1997, Lecture: Inpatient Care of the Headache Patient. Orlando, Florida, July 23-27, 1997.
Diamond Headache Research and Education Foundation: The 11th Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture: Inpatient Care of the Headache Patient, February 18-22, 1998.
Diamond Headache Research and Education Foundation: The 12th Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture: Inpatient Care of the Headache, Palm Springs, California, February 16-20, 1999.
National Symposium on Women's Health, Lecture: Managing Migraine. Chicago, Illinois, November 7, 1998.
103rd Annual Osteopathic Association Meeting - Rational Approach to Migraine Therapy: Solutions with Triptans, Lecture: Overview of Efficacy and Safety of New Agents. New Orleans, Louisiana, October 8, 1998.
Diamond Headache Research and Education Foundation: Headache Update 1998, Lectures: Inpatient Care of the Headache Patient and Headaches in the Elderly. Orlando, Florida, July 21-26, 1998.
American Osteopathic Association 104th Annual Convention and Scientific Seminar Migraine Evaluation and Treatment: Case Management Studies: Lecture: Triptan Therapy: When and How to Use. San Francisc, California, October, 1999.
Diamond Headache Research and Education Foundation: Headache Update 1999, Lectures: Inpatient Care of the Headache Patient and Clinical Trials in Headache, Orlando, Florida, July 20-24, 1999.
The Management of the Headache Patient, Lecture: Epidemiology / Economic Impact of Migraine. Oakbrook, Illinois, October 24, 1999.
American Osteopathic Association, National Symposium on Women's Health, Managing Migraines. San Francisco, California October 23, 1999
Diamond Headache Research and Education Foundation: The 13th Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture: Inpatient Care of the Headache Patient. Palm Springs, California, February 15-19, 2000.
IntraMed Educational Group and the Dannemiller Memorial Educational Foundation, Fairmont Hotel, New Treatment Options for the Management of Pain: The Role of Anticonvulsants, Clinical Manifestation and Treatment of Migraine. Chicago, December 11, 1999.
Diamond Headache Research and Education Foundation: Headache Update 2000, Lecture: Inpatient Care of the Headache Patient. Orlando, Florida, July 18-22, 2000.
Diamond Headache Research and Education Foundation: The 14th Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture: Inpatient Care of the Headache Patient. Palm Springs, California, February 13-17, 2001.
Society for Pain Practice Management, 14th Annual Pain Management Symposium, Headache & Facial Pain Workshop: 1) Evaluation of the Difficult Headache Patient - The Art & Science, 2) Cluster Headache - Identification & Treatment, 3) Migrai, 2001.
Diamond Headache Research and Education Foundation: Headache Update 2001, Lecture: Inpatient Care of the Headache Patient, Orlando, Florida, July 17-21, 2001.
American Osteopathic Association, National Symposium on Women's Health, CME Lecture: Managing Migraine, St. Louis, Missouri, November 17, 2001.
Diamond Headache Research and Education Foundation: Headache Update 1997, The Practicing Physician's Approach to the Difficult Headache Patient, Lecture: Migraine. Palm Springs, California, December 5-6, 1997.
American Occupational Health Conference, Migraine Mentors Program, Lectures: What is Migraine Mentors? and Impact of Migraine on Productivity in the Workplace. Chicago, Illinois April 16, 2002.
American College of Osteopathic Obstetricians and Gynecologists, 69th Annual Convention, Lecture: Hormones and Headache Marco Island, Florida, March 17, 2002.
American Headache Society, Lecture: Role of the Primary Care Physician in the Evaluation and Treatment of Headache: Pharmacologic Treatment Options. Scottsdale, Arizona, October 30-November 6, 2000.
Section Chair, American Association for the Study of Headache, 36th Annual Meeting, Chicago, Illinois, June 24-26, 1994.
Chair, American Headache Society, 44th Annual Scientific Meeting, Lectures: Headache for Primary Care: Advancing Clinical Applications. Seattle, Washington, June 20, 2002.
44th Annual Scientific Meeting of the American Headache Society, Headache for Primary Care: Advancing Clinical Applications. Lecture: How Migraine Evolves, Seattle, Washington, June 20, 2002.
14th Annual Migraine Trust International Symposium; Issues in Clinical Management of Headaches, Presentation: Topiramate Prophylaxis in Patients Suffering from Migraine with Aura: Results from A Randomized, Double-Blind, Placebo-Controlled Trial. London, England, September 26, 2002
Diamond Headache Research and Education Foundation: The 15th Annual Practicing Physician's Approach to the Difficult Headache Patient Symposium, Lecture: Inpatient Care of the Headache Patient. Palm Springs, California, February 12-16, 2002.
Diamond Headache Research and Education Foundation: Headache Update 2002 Symposium, Lectures: Alternative Therapies in Headache and Inpatient Care of the Headache Patient, Orlando Florida, July 18-20, 2002.
Diamond Headache Research and Education Foundation: The 16th Annual Practicing Physician's Approach to the Difficult Headache Patient Lecture Symposium: Inpatient Care of the Headache Patient, Palm Springs, California, February 11-15, 2003
Diamond Headache Research and Education Foundation Clinic Research and Educational Foundation, Satellite Symposium, Migraine: Treatment Approaches Make a Difference, Orlando, Florida, July 16, 2003
Society for Pain Practice Management, "Starting a Pain Center the Nuts and Bolts, " Lecture (1): How to Diagnosis the Difficult Headache Patient- A Road Map for Success. Lecture (2) Cluster Headache- How to Identify, Evaluate, and Treat., 2003.
Diamond Headache Research and Education Foundation: Headache Update 2003 Symposium, Lecture (1): Alternative T Diamond Headache Research and Education Foundation: Headache Update - Diagnosis and Management Symposium, Lecture: Migraine Therapy - Prophylaxis. Chicago, Illinois, Novemb, 2003.
American Academy of Family Physicians' 2004, Meet the Headache Experts, Orlando, Florida, October 15, 2004
Diamond Headache Research and Education Foundation: The 17th Annual Practicing Physician's Approach to the Difficult Headache Patient Symposium, Lecture (1): Cluster Headache and Cranial Neuralgias. Lecture (2): Inpatient Treatment of Headache Palm Springs, California, February 10-15, 2004.
Diamond Headache Research and Education Foundation: Headache Update 2004 Symposium, Lecture (1): Inpatient Care of the Headache Patient. Lecture (2): Alternative Therapies in Headache. Orlando, Florida, July 13-17, 2004.
American Osteopathic Association, Focus on Healthcare Delivery - Women and Minorities; Lecture: Current Therapies in Treating Migraines, Moscone Convention Center, San Francisco, California, November 7, 2004.
Diamond Headache Research and Education Foundation: Update in Headache Symposium, Lecture: Inpatient Treatment of Headache, Chicago, Illinois, November 6, 2004.
Diamond Headache Research and Education Foundation: Headache Update 2005 Symposium, Lecture (1): Inpatient Care of the Headache Patient. Lecture (2): Cluster Headache and Cranial Neuralgias, Orlando, Florida, July 12-16, 2005.
Diamond Headache Research and Education Foundation: The 18th Annual Practicing Physician's Approach to the Difficult Headache Patient Symposium, Lecture (1): Inpatient Treatment of Refractory Headaches. Lecture (2): Cluster Headache and Cranial Neuralgias, Palm Springs, California, February 15-18, 2005.
Chair, Headache Update 2005, Update on Migraine Therapy, Orlando, Florida, July 14, 2005.
Postgraduate Institute for Medicine, Fall Symposium CME Lecture: Preventative Treatment of Chronic Daily Headache, Chicago, Illinois, November 12, 2005.
Diamond Headache Research and Education Foundation: Update in Headache Symposium, Lecture: Inpatient Treatment of Headache, Chicago, Illinois, November 5, 2005.
Diamond Headache Research and Education Foundation: The 19th Annual Practicing Physician's Approach to the Difficult Headache Patient Symposium, Lecture (1): Outpatient Modalities for Chronic Daily Headache. Lecture (2): Cluster Headache and Cranial Neuralgias. Lecture (3): Referral to the Headache Specialist: A Patient Centered Approach, Pal, 2006.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture: Inpatient Treatment of Headache, Indianapolis, Indiana, October 7, 2006.
Diamond Headache Research and Education Foundation: Headache Update 2006 Symposium, Lecture (1): Inpatient Care of the Headache Patient. Lecture (2): Cluster Headache and Cranial Neuralgias, Orlando, Florida, July 11-15, 2006.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture (1): An Overview of Migraine and Chronic Daily Headaches. Lecture (2): Inpatient Treatment of Headache, Minneapolis, Minnesota, May 19, 2007.
Diamond Headache Research and Education Foundation Research and Education Foundation: The 20th Annual Practicing Physician's Approach to the Difficult Headache Patient Symposium, Lecture (1): Cluster Headache and Cranial Neuralgias. Lecture (2): Inpatient Treatment of Refractory Headaches. Palm Springs, California, February 13-17, 2007.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture: Inpatient Treatment of Headache, Chicago, Illinois, November 18, 2006.
Chair, Symposium, Giving Voice to Migraine: Improving Treatment & Communication for Better Patient Care, Palm Springs, California, February 14, 2006
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture: Reversal and Control of the Acute Migraine Attack, Dearborn, Michigan, October 28, 2006.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture (1) Prophylactic Treatment of Frequent Migraine Attacks. Lecture (2): Inpatient Treatment of Headache, Chicago, Illinois, November 17, 2007.
Diamond Headache Research and Education Foundation Research and Education Foundation: Headache Update 2007 Symposium, Lecture (1): Cluster Headache and Cranial Neuralgias. Lecture (2): Inpatient Care of the Headache Patient, Orlando, Florida, July 16-21, 2007.
The 15th International Headache Research Seminar, Lecture: Hospitalization of Headache Patients: Why, When, and How? Copenhagen, Denmark, March 10, 2006
49th Annual Scientific Meeting of the American Headache Society (AHS) Meeting, Lecture: Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan with Acetaminophen for the Acute Treatment of Migraine, Chicago, Illinois, June 9, 2007.
National Headache Foundation Research Summit, Genetics of Headache: Do the Genetics of Histamine Metabolism Predict Response to Treatment with Histamine in Cluster Headache? Palm Springs, California, February 10, 2004.
National Headache Foundation Research Summit, Lecture: Botulinum Toxin Type A in The Treatment of Transformed Migraine Headache. Palm Springs, California, February 15, 2006.
17th International Headache Research Seminar, Lecture: Inpatient Headache Units, Chicago, Illinois, March 8, 2008.
NATIONAL:
Headache Update 2001, Spotlight on Headache Prevention, (Satellite Program at Headache Update 2001) Pharmacoeconomics of Prevention, Orlando, Florida, July 18, 2001.
Symposium, New Advances in Preventing Migraine, Orlando, Florida, July 18, 2003.
Chair, Symposium: Breaking the Barriers to Migraine Prevention, San Diego, California, April 4, 2003.
Symposium, Understanding the Scientific Basis to Migraine Management, Palm Springs, California, February 12, 2004.
Symposium, Optimizing Patient Care in Migraine: A Case Based Approach, Orlando, Florida, July 16, 2004.
Symposium, Acute Treatment of Migraine: Maximizing Treatment Success, Orlando, Florida, July 15, 2004.
Satellite Symposium, Lecture: Understanding the Difference between the Triptans and DHE in Migraine Treatment Options. Scottsdale, Arizona, February 20, 2008.
.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture (1) Cluster Headache and Cranial Neuralgias. Lecture (2): Inpatient Care of the Headache Patient, Chicago, Illinois, July 15-19, 2008.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture (1) Management of the Difficult Cluster Headache Patient. Lecture (2): Inpatient Treatment of Headache, Chicago, Illinois, May 17, 2008.
Diamond Headache Research and Education Foundation Research and Education Foundation: The 21st Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture (1): Cluster Headache and Cranial Neuralgias. Lecture (2): Inpatient Treatment of Headache, Scottsdale, Arizona, February 18-22, 2008.
Section Chair, Headache Update 2008, Acute Care of Headache, Orlando, Florida, July 16, 2008
4th Annual Clusterbusters Conference and AGM, Cluster Headache, Rosemont, Illinois, September 19, 2009.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture (1) Cluster Headache. Lecture (2): Inpatient Treatment of Headache, Chicago, Illinois, July 13-18, 2009.
Diamond Headache Research and Education Foundation Research and Education Foundation: The 22nd Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture (1): Cluster Headache. Lecture (2): Inpatient Migraine Management, Scottsdale, Arizona, February 9-13, 2009.
Diamond Headache Research and Education Foundation Research and Education Foundation: Update in Headache Symposium, Lecture (1) Acute Therapies of Migraine. Lecture (2) Inpatient Treatment of Headache, Chicago, Illinois, November 21, 2009
Diamond Headache Research and Education Foundation Research and Education Foundation: The 23rd Annual Practicing Physician's Approach to the Difficult Headache Patient, Lecture (1): Cluster Headache and Cranial Neuralgias. Lecture (2): Inpatient Treatment of Headache, Scottsdale, Arizona, February 8-13, 2010.
REGIONAL:
Illinois Association of Osteopathic Physicians and Surgeons, Midyear Convention, Lecture: Headache: The Diamond Approach. Oak Brook, Illinois, December 2, 1984.
Central Ohio Neurologic Society, Lecture: Management of the Difficult Headache Patient. Columbus, Ohio, May 8, 1985.
Saint Anthony Medical Center, Are Migraines a Headache for You? Lectures: Diagnosis and Treatment of Migraine, Management of the Difficult Migraine Patient. Columbus, Ohio, May 8, 1985.
Brentwood Hospital, Lecture: Migraine: Its Diagnosis and Treatment. Warrensville Heights, Ohio, May 9, 1985.
Winnebegoland District Nurses Association Lectures: Diagnosis and Treatment of Organic Headaches, Diagnosis and Treatment of Muscle Contraction Headaches, and Establishment of the Headache Clinic. Appleton, Wisconsin, May 14, 1986.
North Carolina Academy of Family Physicians, Lecture: Teenager with a Headache. North Carolina, July 1, 1986.
Cleveland Academy of Osteopathic Medicine, 22nd Annual Meeting, Lecture: Headache Update. Cleveland, Ohio, January 16, 1987.
Clinical Pharmacology Conference, Chicago Medical School, Lecture: Methodology of Pharmacologic Trials for the Treatment of Migraine. Chicago, Illinois, March 3, 1987.
Diamond Headache Research and Education Foundation: Headache Update 1987, Lectures: Migraine
Headache Variants and Muscle Contraction Headache. Chicago, Illinois, May 1, 1987
Cleveland Academy of Osteopathic Medicine, 23rd Annual Postgraduate Seminar, Lecture: Pediatric and
Adolescent Headache. Cleveland, Ohio, January 16, 1988.
West Virginia Chapter, American Academy of Family Physicians, Lecture: Calcium Channel Blockers in the Prophylaxis of Migraine Headache. Morgantown, West Virginia, April 15, 1989.
Diamond Headache Research and Education Foundation: Headache Update 1988, Lecture: Migraine Variants. Cincinnati, Ohio, April 16, 1988.
Internal Medicine Update, Orlando Regional Medical Center, Lecture: Differentiation and Management of Headache. Orlando, Florida, March 4, 1988.
Lorain Academy of Osteopathic Medicine, Lecture: Calcium Channel Blockers in the Treatment of Migraine Headache, May 19, 1989.
Virginia Osteopathic Medicine Association, 83rd Annual Meeting, Lecture: Headache Overview and Migraine Headache, May 10, 1989.
14th Annual Presentation by the Alamo Chapter of the Texas Academy of Family Physicians, San Antonio Mid-Winter Seminar, Family Practice, Lecture: Migraine: Its Diagnosis and Treatment. San Antonio, Texas, February 16, 1990.
Headache and Pain Management Symposium, Saint Thomas Medical Center, Lecture: Migraine and Its Variants. Cuyahoga Falls, Ohio, February 14, 1990
The Chronic and Difficult Headache and Back Pain Patient, Miami Valley Hospital, Panel Discussion: "Chronic Daily Headache", Physician's Grand Rounds and Lectures: Latest Pharmacological Treatment of Headache. Lectures: Facial Pain and Neuralgia, Differenti, 1990.
Regional Pain Seminar, The University of Tennessee, Memphis College of Medicine, Department of Anesthesiology Pain Center, Lecture: Mixed Headaches - The Diagnosis and Treatment. September 21, 1990
Orlando Regional Medical Center and University of Florida College of Medicine, 12th Annual Internal Medicine Series, Lectures: New Treatment for Migraines, Treatment of Mixed Headaches. Orlando, Florida, March 12, 1991.
11th Annual Florida Society American College of General Practice, National General Practice Update, Lecture: Handling Headaches: Do NSAIDS Have a Role? St. Petersburg, Florida, 1991.
Missouri Association of Osteopathic Physicians and Surgeons, Lecture: The Use of CDS in the Management of Headaches. Kansas City, Missouri, October 4, 1992.
The Annual Alumni Conference and Family Medicine in Review, Lecture: Migraine and Mixed Headaches. Mt. Sterling, Ohio, October 3, 1992
Colorado Society of Osteopathic Medicine, Lectures: Headaches, Neurologic Exam & Evaluation of the Headache Patient. Keystone, Colorado, February 22, 1993.
Oklahoma Osteopathic Association's, "Osteopathic Medicine: Back to the Future", Winter Seminar, Lecture: The Use of CDS in the Management of Headaches. Tulsa, Oklahoma, January 24, 1993
Kansas Association of Osteopathic Medicine Annual Meeting, Lecture: Migraine & Mixed Headache. Overland Park, Kansas, May 15, 1993.
American College of Emergency Physicians, Minnesota Chapter, Advances in Emergency Medicine, Lecture: ED Evaluation and Management of Headache. Minneapolis, Minnesota, May 7, 1993.
Day of Medicine Review III, Doctors Hospital, Lectures: Review of Migraine Headaches and Headaches in the Pediatric Patient. Columbus, Ohio, April 3, 1993
Family Practice Review, Kirksville College of Osteopathic Medicine, Lectures: Migraine Headache: An Update, Pediatric Headache. Lake Ozark, Missouri, July 22-24, 1994.
Visiting Faculty Program in Pain Management, Saint Agnes Medical Center, Lecture: Diagnosis and Treatment of Migraine Headache Pain. Philadelphia, Pennsylvania, April 27, 1994.
Visiting Professor, Noon Lecture Presentations, Brentwood Hospital, Lecture: Diagnosis and Treatment of Migraine Headache Pain. Warrensville Heights, Ohio, April 20, 1994
Primary Care Physician Update, Medical College of Ohio Campus, Lecture: Primary Care Approach to Headache. Toledo, Ohio, March 11, 1995.
Rocky Mountain Osteopathic Foundation, Migraine Conference, Lecture: Pathophysiology of Migraine and Clinical Experience with Various Treatment Options. Denver, Colorado, October 12, 1994.
The 11th Annual Family Practice Symposium, Lecture: Migraine Headaches: Current and Effective Pharmacologic Approaches. Pewaukee, Wisconsin, November 3, 1995.
Winter Scientific Seminar, Missouri Society of the American College of Osteopathic Family Physicians, Lecture: Diagnosis of Migraine Headache Pain. Kansas City, Missouri, January 25, 1996.
Family Practice Education Day, Doctors Hospital, Lecture: Migraine Headache. Columbus, Ohio, May 1, 1996.
32nd Annual Postgraduate Seminar, Cleveland Academy of Osteopathic Medicine, Lecture: Migraine.
Cleveland, Ohio, January 17-18, 1997.
Current Management of Your Difficult Headache Patient, Lecture: Cluster Headache-Diagnosis and Treatment. Chicago, Illinois, December 7, 1996.
Medical College of Wisconsin, Lectures: Complicated Migraine and Migraine Variants, Inpatient Care of the Headache Patient, Migraine Prophylaxis. Milwaukee, Wisconsin, July 18, 1997.
Walter Reed Army Medical Center, Lecture: Migraine. Washington, D.C., July 15-16, 1997.
Black Hills Neurology Seminar, Advances in Clinical Adult Neurology, Lectures: Headaches: Muscle Contraction and Post-Traumatic, Migraine Headaches: Evaluation & Treatment, and Cluster Headaches: Diagnosis and Treatment. February, 1990.

COMMITTEE SERVICE:
Medical College
2014 - 2017 Member, Library Committee
2014 - 2015 Member, Institutional Review Board, Medical College of Wisconsin
2016 - Present Present, Chair, Department of Neurology Continuing Education Course Committee
2017 - Present Alternate Delegate, Faculty Council
 
Hospital
09/09/16 - 1610 CGRP and other biological markers of migraine: potential for
1973 - 1974 University of Wisconsin, Madison, Student Faculty Committee on Physician's Assistant degree program development
1973 - 1975 University of Wisconsin, Madison, Student Faculty Committee on Biomedical Engineering program development
1981 - 1983 Clinical Associate Professor, Department of Family Medicine, Ohio University College of Osteopathic Medicine, Athens, Ohio. Taught Headache Didactic at Brentwood Campus. Differential Diagnosis
1983 - 2012 working in conjunction with the National Headache Foundation provided between 2 and 12 educational programs per year
1984 - 1993 Rush University Neurology Residency, elective rotation, Chicago IL
1985 - 1989 Member, Research Committee, Louis A. Weiss Memorial Hospital
1985 - 2010 Diamond Headache Clinic Research and Educational Foundation, Chicago, IL. Worked with original course directors, Seymour Diamond MD and Donald Dalessio, MD to develop an annual ACCGME approved educational program. Worked with them and then with other co-directors over the years to oversee the expansion of the course to two 5-day programs with an avera
1985 - 1989 Member, Pharmacy and Therapeutic Committee, Louis A. Weiss Memorial Hospital
1987 - 1989 Swedish American Hospital, Chicago, IL. Elective rotation
1988 - 2005 working in conjunction with First Chicago National Bank and its successor and their medical director provided lectures and developed online educational tools for diagnosis of migraine, its treatment with emphasis and self-management tools
1988 - 1989 Universidad Nacional de Colombia 1989 Fellowship training site
1989 - 1993 Chairman, Research Committee, Louis A. Weiss Memorial Hospital
1989 - 1991 Member, Institutional Review Board, Louis A. Weiss Memorial Hospital
1990 - 1991 Ankara University Medical School, Ankara Turkey, Fellowship training site
1991 - 1993 Chairman, Institutional Review Board, Louis A. Weiss Memorial Hospital
1998 - 2010 Affiliate Instructor and formerly Visiting Lecturer, Department of Family Medicine, Midwestern University, Chicago College of Osteopathic Medicine, Downers Grove
1998 - 2007 working in conjunction with Johnson and Johnson provided ongoing programs to patient, businessmen pharmacists on impact of headache in the workplace
1998 - 2010 University of Iowa, Clinical Pharmacy PharmD program, 4 to 6-week elective rotation
1998 - 2000 University of Iowa School of Pharmacy development of clinical clerkship in Headache Medicine for Pharmacology Doctor program
1999 - 2012 Clinical Assistant Professor, Department of Family Medicine, Rosalind Franklin University of Medicine and Science, Chicago Medical School, North Chicago
2001 - 2003 Moscow Medical Academy, Moscow, Russia, Fellowship training site
2002 - 2003 Member, Institutional Review Board, Saint Joseph Hospital, Chicago, IL
2004 - 2005 Member, Pharmacy and Therapeutics Committee, Saint Joseph Hospital, Chicago, IL
2007 - 2008 Michigan State University College of Medicine elective rotation
2008 - 2009 Member, Ethics Committee, Saint Joseph Hospital, Chicago, IL
2008 - 2009 Diamond Headache Clinic, developed the UCNS headache medicine fellowship program which was approved in 2010
2008 - 2009 Diamond Headache Clinic, Chicago, IL, developed with colleagues the partnership with Loyola university school of Medicine, Department of Neurology fellowship program
2010 - 2013 Baylor University Medical Center, developed the UCNS headache medicine fellowship program which was approved in 2011 and trained 1 candidate in 2013-2014
2010 - Present Baylor University Medical Center, Dallas TX, lead the development, organization and implementation of multi-disciplinary headache medicine program that had 10 dedicated inpatient beds as well as outpatient infusion and multi-disciplinary service that expanded between
2010 - 2011 Baylor University Medical Center developed and received first pass approval of the UCNS fellowship program in headache Medicine, obtained recognition from the Texas Medical Board of a non ACCGME/non ABMS affiliated fellowship program. This was the first UCNS program approved in the State of Texas
2013 - Present Associate Professor, Department of Neurology Medical College of Wisconsin, Milwaukee, Wisconsin. ½ day rotation in clinical neurology MS3/4. Clinical rotation: headache medicine, Pediatric Neurology.
2013 - Present community teaching twice a year under auspices of Froedtert Hospital
2013 - Present Present, the Medical College of Wisconsin, Department of Neurology. Developed UCNS headache medicine fellowship in 2010 and have trained and retained 2 trainees to date
2013 - 2014 Medical College of Wisconsin, Department of Neurology, developed the UCNS fellowship in Headache Medicine
2015 - 2017 Froedtert and the Medical College of Wisconsin. Lead the development, organization and implementation of a multi-disciplinary program dedicated to the assessment and treatment of patients with chronic migraine. This included play a central role in the development of a u
2015 - Present University of Mississippi School of Medicine, Department of Neurology, elective rotation
2017 - Present Member, Comprehensive Pain Steering Committee, Froedtert and the Medical College of Wisconsin
MEDICAL COLLEGE TEACHING
Medical student teaching
Graduate Student Education
Resident and Fellow Education
Continuing Medical Education
therapeutic impact 9/24/2014 m14064 Chronic Migraine: Beyond Traditional Therapy
Community/Lay Activities
.
.
MCW STUDENTS, FACULTY, RESIDNETS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Graduate Students
Richard Armstrong. Research Assistant Department: Microbiology and Molecular Genetics 9/2015-4/2017 Career Planning
Fellows:
Fallon Schloemer
EXTRAMURAL STUDENT, FACULTY, RESIDENTS AND CLINCIAL AND RESEARCH FELLOWS MENOTORED:
Undergraduate Students:
Richard yates md PhD candidate 1/15- 1/16
Celestine Arambulo, DO 6/1990 - 5/2010 career guidance and development
Undergraduate Student, Faculty
George Nissan DO 7/2002 present ongoing mentoring from career planning to career development
Resident/ Faculty
Ferhad Bashir, MD, 9/2015 - 6/2016 career development
Amit K. Masih, MD 2/2008- 6/2010, career development
Jeffrey S. Royce, MD 3/2002- 7/2009 career development
Jennifer Lynn Bickel, MD 3/2005-5/2008 career development
Paul winner, DO, FAAN, FAHS 3/2000- 6/2005 career development
Ernesto Aycardi, MD 7/1988 -7 1991 career development
Faculty
Christy M. Jackson, MD FAAN, 3/2000 - 6 2012 career development
Duren Michael Ready, MD 6 1999- Present, career development
A Kemal Erdemoglu, MD, 1990 - Present, career development
Glen D. Solomon, MD, FACP 3/1984-5/1987 career development
PROGRAMATIC DEVELOPMENTS:
Undergraduate Student
Graduate Education
Fellow
Clinician
Research
Developed a successful model for a clinic based contract research organization (CRO) that successfully bid on and conducted 3 major multi-center trials of phase IIIB research activity.
Clinical Programs
COMMUNITY SERVICEACTIVITY:
Concordia University, River Forest, Illinois: President's Advisory Council, 2006 - 2010
Lutheran World Relief, Baltimore, Maryland President's Council, 2009 - 2012
Order of the Knights of St John 2011- 2013
Participant Mentoring Program, Wisconsin Alumni Foundation, 2013 - Present
Southeast Wisconsin Chapter Chair, Wisconsin Alumni Foundation. 2017- Present
 


BIBLIOGRAPHY
Books, Chapters, and Reviews
1. Cowan, R, Green M, Freitag, FG. Ed. Chronic Headache. Springer in publication.
2. Shumate, D, Freitag, FG. Neuromodulation in Chronic Headache. In Cowan, R, Green M, Freitag, FG. Ed. Chronic Headache. Springer in publication.
3. Diener, HC, Freitag, FG. Medication Overuse. Cowan, R, Green M, Freitag, FG. Ed. Chronic Headache. Springer in publication.
4. Frederick G. Freitag, Johnathon Florczak; Cluster Headache. In: Seymour Diamond, Roger
5. K. Candy, Merle L. Diamond, Mark W. Green and Vincent T. Martin, editors, Headache and Migraine
6. Biology and Management. Oxford: Academic Press, 2015, pp. 135-148. ISBN: 978-0-12-800901-7.
7. Freitag FG, Black SB. Establishing a Headache Center: From Concept to Practice. Baxter, Hamilton, Ontario, CA 2011.
8. Freitag, FG. Tension Headache. In Pain Management. Edited by Steven D Waldman, Elsevier Saunders, Philadelphia, Pennsylvania. 2011. Pp428-436.
9. Freitag FG. Cluster Headache. In: Clinician's Guide to Chronic Headache and Facial Pain. Edited by Gary W. Jay New London, Connecticut. Informa Healthcare 2010. Part I: Headache, 76-95.
10. Silberstein SD, Freitag FG, Bigal ME. Migraine Treatment. In: Stephen D. Silberstein, Richard B. Lipton, David W. Dodick - Wolff's Headache and Other Head Pain. Oxford University Press, New York, 2008; 177-292.
11. Freitag FG. In: Migraine and Other Headache Disorders. Edited by Richard Lipton, Marcelo Bigal. Taylor & Francis Group. New York, New York. Inpatient Management and Invasive Treatment Strategies for Migraine and Chronic Daily Headaches. Chapter 25:393-412.
12. Freitag FG. In: Headache Clinics: Organization, patients and treatment. Frontiers in Headache Research Series. Edited by Rigmore Jensen, Hans-Christoph Diener, Jes Olesen. Oxford University Press Inc. New York, 2007. Session II Patient characteristics in headache clinics, Chapter 12:73-84.
13. Freitag FG. In: Pain Management. Tension-Type Headache. Edited by Steven D. Waldman. Saunders/ Elsevier, Philadelphia, Pennsylvania, 2007. Vol. 1; C43:464-473.
14. Freitag FG. In: Headache - A Guide for the Primary Care Physician. Other Primary and Secondary Headache Disorders, American College of Physicians, Key Diseases Series, Philadelphia, Pennsylvania, 2006, Ed. Loder EW, Martin VT, 137-155.
15. Freitag FG, Feoktistov A. A Woman with Rebound Headache and Intermittent Paralysis. Advanced Therapy of Headache, 2nd Edition. BC Decker Inc. Hamilton, Ontario, 2006, Chapter 47, 259-264.
16. Freitag FG. Foreword In: Tell Me What to Eat If I Have Headaches and Migraines. New Page Books, A Division of The Career Press, Inc. Franklin Lakes, New Jersey, 2005, 7-10.
17. Freitag FG, Cady R. The National Headache Foundation Standards of Care. 3rd Edition. National Headache Foundation, 2001.
18. Silberstein SD, Saper JR, Freitag FG. Migraine: Diagnosis and Treatment. In: Stephen D. Silberstein, Richard B. Lipton, Donald J. Dalessio - Wolff's Headache and Other Head Pain. Oxford University Press, New York, 2001; 121-237.
19. Freitag FG. Headache Clinics and Inpatient Treatment Units for Headache. In: Diamond S, Dalessio DJ, The Practicing Physician's Approach to the Treatment of Headache, 6th Edition, Baltimore, Maryland, Ed. ML Diamond, G Solomon, Lippincott Williams & Wilkins.
20. Freitag FG. Medical Management of Cluster Headache. In: Headache: Diagnosis and Treatment. Ed. C. David Tollison, Robert S. Kunkel. Lippincott Williams & Wilkins, Baltimore, Maryland, 1993.
21. Diamond S, Freitag FG, Diamond ML. Migraine. In: Principles and Practice of Emergency Medicine. 3rd Edition, Philadelphia, Ed. GR Schwartz, CG Cayten, MA Mangelsen, TA Mayer, BK Hanke, Lea & Febiger, 1992.
22. Diamond S, Freitag FG. Headache Following Cervical Trauma. In: Painful Cervical Trauma. Baltimore, Maryland, CD Tollison, JR Satterthwaite, Lippincott Williams & Wilkins, 1992.
23. Freitag FG. Headache Clinics and Inpatient Units for Treatment of Headache. In: Diamond S, Dalessio DJ, The Practicing Physician's Approach to the Treatment of Headache, 5th Edition, Baltimore, Ed. S Diamond, DJ Dalessio, Lippincott Williams & Wilkins, 1992.
24. Freitag FG, Diamond S, Greenberg I, Urban GJ. MRI Changes in Migraine. In: New Advances in Headache Research, 2. Ed. F. Clifford Rose, Smith-Gordon and Company, Ltd., London, 1991; 53-61.
25. Diamond S, Freitag FG. A Double-Blind Trial of Flunarizine in Migraine Prophylaxis. In: New Advances in Headache Research, 2. Ed. F. Clifford Rose, Smith-Gordon and Company, Ltd., London, 1991; 349-354.
26. Diamond S, Freitag FG, Chu G, Diamond ML. Transnasal Butorphanol (TNB) in the Acute Treatment of Migraine: A Placebo-Controlled Comparative Study Versus Intramuscular Methadone. In: New Advances in Headache Research, 2. Ed. F. Clifford Rose, Smith-Gordon and Company, Ltd., London, 1991; 319-324.
27. Mosnaim AD, Huprikar S, Wolf ME, Freitag FG, Diamond S. Studies of Platelet Monoamine Oxidase Activity in Female Migraineurs: An Old Story Revisited. In: New Advances in Headache Research, 2. Ed. F. Clifford Rose, Smith-Gordon and Company, Ltd., London, 1991; 135-139.
28. Freitag FG, Diamond ML. Emergency Treatment of Headache. In: Clinics of North America. 1991; 75(3):749-761.
29. Freitag FG. Headaches in the Elderly. In: Drug Therapy for Headache. Ed. RM Gallagher, Marcel Dekker, New York, 1990; 183-201.
30. Freitag FG. Beta Blocker in the Treatment of Migraine. In: Migraine Headache Prevention and Management. Ed. S Diamond, Marcel Dekker, New York, 1990; 57-97.
31. Freitag FG, Diamond S.: The Long-Term Use of Monoamine Oxidase Inhibitors in the Management of Headache. In: New Advances in Headache Research. Ed. F.C. Rose, Smith Gordon, London, 1989; 301-304.
32. Diamond S, Solomon GD, Freitag FG. Headache in Sports. In: Sports Neurology. Ed. BD Jordan, P Tsairis, RF Warren, Aspen Publishers, Rockville, Maryland, 1989; 127-132.
33. Diamond S, Solomon GD, Freitag FG. Differential Diagnosis of Headache. In: Handbook of Chronic Pain Management. Ed. ED Tollison, Lippincott Williams & Wilkins, Baltimore, Maryland, 1989.
34. Freitag FG, Diamond S, Solomon GD. Antidepressants in the Treatment of Mixed Headache: MAO Inhibitors and Combined Use of MAO Inhibitors and Tricyclic Antidepressants in the Recidivist Headache Patient. In: Advances in Headache Research. Ed. F. Clifford Rose, Libbey, 1987; 271-275.
35. Freitag FG, Diamond S. The Long-Term Use of Monoamine Oxidase Inhibitors in The Management of Headache. In F.C. Rose (Ed.) New Adv in Headache Res. Smith-Gordon, 1989.
36. Freitag FG, Diamond S, Solomon GD. Antidepressants and The Treatment of Mixed Headache: MAO Inhibitors and Combined Use of MAO Inhibitors and Tricyclic Antidepressants in The Recidivist Headache Patient. In F.C. Rose (Ed.) Adv in Headache Res. John Libbey & Co. Ltd., 1987; 271-275.
37. Diamond S, Mosnaim AD, Freitag FG, Wolf ME, Lee G, Solomon GD. Plasma Methionine-Enkephalin Levels in Patients with Cluster Headache. Longitudinal and Acute Studies. In F.C. Rose (Ed.) Adv in Headache Res. John Libbey & Co. Ltd. June 1987; 209-215.
38. Freitag FG. Headache Clinics and Inpatient Units for Treatment of Headache. Diamond S, Dalessio DJ. In: The Practicing Physician's Approach to Headache, 4th Edition. Lippincott Williams & Wilkins, Baltimore, Maryland, 1986.
39. EDITIORIAL, LETTERS TO EDITOR, OTHER
40. Freitag FG. As The "Circle Turns Round" Back to Neurovascular Basis in Migraine [editor's message]. J Am Osteopath Assoc. 2005; 105(4 suppl 2): cover 2-S1.
41. Freitag FG. Health and Wellness, Know Your Nuisance: Headaches. American Osteopathic Assoc. June 2005.
42. Freitag FG. Consortium Publishes Guidelines to Lessen "Headache" Of Treating Migraine. JAOA. June 2000; 100(6):348.
43. Freitag FG. H. Pylori and Headache: Cause or Commotion? Headache Q, 1998; 9:23-24.
44. Freitag FG. Comments on Palpatory Examination. J Am Osteo Assoc. 1987; 87:455. Letter.
45. Prager J, Diamond S, Freitag FG. Link Between Food Allergy, Migraines: Inconclusive. Am Med News. February 1, 1985; 6. Letter
46. MONOGRAPHS:
47. The Center for Health Care Education/Pfizer, Inc. Satellite Symposium, Back to the Future: Our Understanding of Migraine and Its Treatment Through the Ages, Palm Springs, California, February 15, 2006.
48. Freitag FG, Faculty. National Institute of Neurological Disorders and Stroke. 21st Century Prevention and Management of Migraine Headaches. December 2001; 19:1-24.
49. Freitag FG. Headache. College of Physicians and Surgeons, Columbia University. New Insights into the Treatment of Cerebrovascular Disease. Proceedings Monograph. 1990; 20.
50. Diamond S, Freitag FG. Headache. American Academy of Family Physicians Monograph. 1985; 69:1-54.
51. NON-REFERRED JOURNAL PUBLICATIONS/ORIGNIAL PAPERS:
52. Diamond S, Robbins, L, Freitag, FG. Acute Treatment of Cluster Headache. Practical Pain Management 2010. 10(9):56-62,
53. Freitag FG. Headache: Trends in Treatment - Cluster Headache. The Spoken Medical Journals, Audio-Digest Otolaryngology, 42: No.20, 2009.
54. Freitag FG. Headache: Trends in Treatment - Cluster Headache. The Spoken Medical Journals, Audio-Digest Otolaryngology, 42: No.20, 2009.
55. Freitag FG, Blake G. How Do You Optimize the Use of Migraine Prevention Agents? Migraine Management Frequently Asked Questions: Clinician Reviews. April 2006 (S) 19.
56. Freitag FG, Blake G. What Treatments Are Available for Migraine Prevention? Migraine Management Frequently Asked Questions: Clinician Reviews. April 2006 (S) 17-18.
57. Freitag FG, Blake G. When Do You Recommend Migraine Prevention? Migraine Management Frequently Asked Questions: Clinician Reviews. April 2006 (S) 16-17.
58. Freitag FG. Ask the Expert: "Which Preventative Therapies Should I Use for Which Patients?" Excellence in Migraine Management. January 2006; 1(2) 16.
59. Freitag FG. Cluster Headache. Primary Care, June 2004; 31(2): 313-329.
60. Freitag FG. Divalproex in the Treatment of Migraine. Psychopharmacology Bulletin. 2003; 37 Suppl 2:98-115.
61. Freitag FG. Divalproex Sodium Extended-Release for The Prophylaxis of Migraine Headache. Expert Opin Pharmacother. September 2003; 4(9):1573-1578.
62. Diamond S, Freitag FG. A Multi-Faceted Approach to The Patient with Refractory Headache. Consultant. 2000; 40:1640-1646.
63. Diamond S, Freitag FG. Cluster Headache, Part 2: Variants. Dialogues with Dr. Diamond and Colleagues, Headache of the Month. Consultant. March 2000; 40:451-455.
64. Freitag FG. Headaches. Chicago Medicine. March 7, 1999; 21.
65. Freitag FG. The Acute Management of Migraine, Cluster, And Tension-Type Headaches. Neurology Forum. 1993; 4(1):3-14.
66. Freitag FG. Emergency Room Treatment of Headache. Pain Topics. 1990; 4:2.
67. Diamond S, Freitag FG. Nonsteroidal Anti-Inflammatory Agents in The Treatment of Migraine. Current Headache Management. September 1990; 1:3-15.
68. Diamond S, Freitag FG. Current Treatments for Headache. FamPracRe-Cert. March 1989.11(3):25-48.
69. Diamond S, Freitag FG. Treatment of Headache. Clin J Pain. 1989; 5(Suppl. 2): S7-S18.
70. Diamond S, Freitag FG. NSAIDS In Migraine - Examining Their Role. New Ethicals. 1989; 26:17-25.
71. Diamond S, Freitag FG. Do Non-Steroidal Anti-Inflammatory Agents Have a Role in The Treatment of Migraine Headache? Drugs. June 1989; 37:755-760.
72. Freitag FG. Migraine Headache Variants. Clin J Pain. 1989; 5:11-17.
73. Diamond S, Freitag FG. Diagnosing Common Headache Disorders. FamPracRe-Cert. February 1989; 11:67-72.
74. Diamond S, Freitag FG. Post-Traumatic Headache. Trauma. August 1989; 2:7-18.
75. Diamond S, Freitag FG. Intravenous Prochlorperazine For Acute Headache. JAMA. July 1989; 262:501-502.
76. Freitag FG, Gallagher RM. The Mixed Headache Syndrome. J Osteo Med. 1987; 1:28-33.
77. Diamond S, Freitag FG, Solomon GD, Millstein E. Migraine Headache: Working for The Best Outcome. Postgraduate Medicine. June 1987; 81(8):174-183.
78. Diamond S, Freitag FG, Solomon GD. Conquering the Common Headache: A Guide to Diagnosis and Treatment. The Female Patient. June 1987; 12:29-41.
79. Diamond S, Solomon GD, Freitag FG. Cluster Headache. Clin J Pain. 1987; 3:171-176.
80. Freitag FG, Gallagher RM. Migraine Headache. J Osteo Med. 1987; 1:36-43.
81. Freitag FG, Gallagher RM. Cluster Headache. J Osteo Med. 1987; 1:10-18.
82. Freitag FG, Gallagher RM. Muscle Contraction Headache. J Osteo Med. 1987; 1: 8-17.
83. Diamond S, Solomon GD, Freitag FG. Acute Presentation of Migraine. Emergency Decisions March 1987; 3:51-56.
84. Diamond S, Freitag FG, Robbins LD. Exertional Headaches. Neuroview. Jan/Feb 1987; 6-15.
85. Diamond S, Freitag FG, Solomon GD. Controlling Migraine: An Update. The Female Patient. September 1986; 11:40-46.
86. Diamond S, Freitag FG, Prager J. Cluster Headache: New Treatment for Refractory Cases. Mod Med August 1986; 54:111-112.
87. Diamond S, Freitag FG. Migraine Rx: How to Keep the Patient Headache-Free. Modern Medicine. July 1986; 76-86.
88. Diamond S, Freitag FG. The Importance of The History in The Diagnosis of Headache and Facial Pain. Cranio. July 1986; 4(3):197-198.
89. Diamond S, Prager J, Freitag FG. Diet and Headache. Is There a Link? Postgraduate Medicine March 1986; 79(4):279-286.
90. Diamond S, Freitag FG. Depression and Headache. Resident & Staff Physician. November 15, 1985.
91. Diamond S, Prager J, Freitag FG. Sex-Related Headaches. Neuroview. Fall, 1985; 1:1-5.
92. Diamond S, Freitag FG. Depression and Headache. Medical Times. October, 1984; 112(10):35FM-39FM, 43FM-48FM.
93. Diamond S, Freitag FG. Headaches: Significant or Merely Uncomfortable? Contemporary OB/GYN. May, 1984 ;( special issue) 12-16.
94. Diamond S, Freitag FG. The Inpatient Headache Treatment. Keeping Current in The Treatment of Headache. May 1984; 3(1):3-10.
95. Diamond S, Freitag FG, Cohen JS. Cluster Headache with Trigeminal Neuralgia. An uncommon association that may be more than coincidental. Postgraduate Medicine. February 1984; 75(2):165-172.
 
Abstracts
1. Hyalinizing Clear Cell Carcinoma of the Base of Tongue: First Report of a Case Presenting with Headaches (Poster P6.094), Farooq S, Harding Jackson H, Stadler M, Freitag F. Neurology April 5, 2016: 86;16 Supplement P6.094
2. A Case Report of SUNCT Syndrome Responsive to Gliacin. Eross, E.J, Freitag, FG. Headache 54: Sept; 2014;1422.
3. Incidence of Adverse Events with MAP0004 Does Not Increase with Increased Frequency of Dosing: Results from a Long-Term Phase 3 Study (P7.184) Paul Winner5, Sylvia Lucas6, Biao Lu2, Emilee Connors3, Frederick Freitag4 and Shashidhar Kori1+SHOW AFFILIATIONS Neurology April 8, 2014 vol. 82 no. 10 Supplement P7.184
4. Cady RK, O'Carroll CP, Dexter JK, Freitag F, Beach ME. SumaRT/Nap Verses Naproxen in Treatment and Disease Modification of Migraine: A Pilot Study. Cephalalgia, June 2013: 33 ;( 8 Supplements):23-24.
5. Winner P, Lucas S, Lu B, Connors E, Freitag F, Kori S. Incidence of Adverse Events with MAP0004 Does Not Increase with Increased Frequency of Dosing: Results from a Long-Term Phase 3 Study. Cephalalgia, June 2013: 33; (suppl 8): 37.
6. Clark TS, Freitag FG, Robinson RC, Hands A. Improving Function by Targeting Function: Efficacy of an Interdisciplinary Outpatient Program. Cephalalgia June 2013: 33 ;( suppl 8):50-51.
7. Dexter JK, Cady RK, Nett R, Freitag F, Beach ME. Treatment of Chronic Migraine: A Three-Month Comparator Study of Naproxen Sodium vs. SumaRT/Nap. Cephalalgia June 2013: 33 (suppl 8): 53-54.
8. Freitag FG, Diamond S. Disease Severity and Economic Impact of Headache in a Tertiary Headache Treatment Center. Headache, May 2008: F17.
9. Brandes JL, Cady RK, Smith TR, Freitag FG, Linn LS, Farr SJ. Usability of the Sumatriptan DosePro Needle-Free System in Adult Migraineurs during Acute Migraine Attack outside of the Clinic. Headache, May 2008: S2.
10. Diamond S, Freitag FG, Diamond ML. 4mg StatDose Sumatriptan in Naïve Patients. Headache, May 2008: S5.
11. Diamond S, Freitag FG, Diamond ML. Open-Label Trial of Frovatriptan 2.5mg Oral Tablets in Subjects with High Frequency of Migraine. Headache, May 2008: S27.
12. Freitag FG, Heneghan MA. Lunar Headache? Headache, May 2007: S46.
13. Freitag FG, Diamond ML, Skobieranda F, Diamond S. Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan with Acetaminophen for the Acute Treatment of Migraine. Headache, May 2007: OR20.
14. Dodick D, Silberstein S, Saper J, Freitag FG, Cady R, Rapoport AM, Mathew N. Hulihan J, Crivera C, Rupnow M, Mao L, Finlayson G, Greenberg SJ. Disability and Performance of Daily Activities in Chronic Migraine: Results from a Randomized, Double-Blind, Place-Controlled Trial of Topiramate. Headache, May 2007: F54.
15. Silberstein S, Lipton R, Dodick D, Freitag FG, Mathew N, Brandes J, Bigal M, Saper J, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J. Additional Assessment of the Efficacy of Topiramate for the Treatment of Chronic Migraine. Headache, May 2007: F32.
16. Rapoport A, Finlayson G, Freitag FG, Fisher A, Mao L, Wright P. Spectrum of Headache Pain Intensities at Treatment Intervention: Outcome Observations from the AIMS and AEGIS Early Intervention Studies. Neurology 66, March 2006: A42.
17. Mauskop, A, Dodick DW, Frishberg BM, McAllister P, Aurora S, Freitag FG, Silberstein SD. Program to Assess Headache Treatment Strategies: Baseline and Preliminary Results from an Observational Study of Botulinum Toxin Type A Prophylactic Headache Treatment. Neurology 66, March 2006: A177.
18. Lipton R, Bigal M, Stewart WF, Freitag FG, Reed ML. Barriers to Migraine Preventive Medication Use in a Community Sample: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Neurology 66, March 2006: A130.
19. Freitag FG, Diamond S, Diamond ML, Urban GJ, Brooks KE. Botulinum Toxin Type A in the Treatment of Chronic Migraine with Medication Overuse Headache. Neurology 66, March 2006: A224.
20. Lipton RB, Diamond ML, Freitag FG, Bigal M, Stewart WF, Reed ML. Migraine Prevention Patterns in a Community Sample: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache June 2005; (F38) 792.
21. Freitag FG, Greenberg S, Unger JR, Finlayson G, Diamond ML, Fisher A, Hulihan J. Effect of Time to Treatment on Headache Duration: Interim Results From AIMS: AXERT 12.5mg Time versus Intensity Migraine Study. Headache June 2005; (S69) 806.
22. Elkind AH, Greenberg S, Rapoport AM, Finlayson G, Freitag FG, Fisher A, Hulihan J. Evolution to Sensitization and Allodynia: Interim Results From AIMS: AXERT 12.5mg Time versus Intensity Migraine Study. Headache June 2005; (S77) 808.
23. Freitag FG, Lainez MJ, Neto W., Shi Y. Comparing the Incidence of Adverse Events in the Titration and Maintenance Phases of Placebo-Controlled Trials of Topiramate for Migraine Prevention. Headache June 2005; (S107) 821.
24. Freitag FG, McAllister P, Freund B., Schwartz M., DeGryse R, Barron R. Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache in Migraineurs: Effect on Acute Headache Pain Medication Use. Headache June 2005; (S119) 827.
25. Freitag FG, Diamond S, Diamond ML, Urban GJ. A Pilot Study of Divalproex Sodium ER in Chronic Migraine without Medication Overuse Headache. Headache June 2005; (S122) 828.
26. Freitag FG, Diamond S. Treatment of Migraine in Patients Who Historically Fail to Respond to Oral Triptans. Results with Sumatriptan Subcutaneous. Headache May 2004; (F29) 476.
27. Freitag FG, Diamond S. Does Sumatriptan 6mg Subcutaneous Override the Effects of Allodynia on Acute Migraine Outcome? Headache May 2004; (F30) 476.
28. Freitag FG, Kozma CM, Slaton, T, Osterhaus JT, Barron RL. Characterization and Prediction of Emergency Department Use in Chronic Migraine Patients. Headache May 2004; (F50) 485.
29. Freitag FG, Diamond S. A Single Center, Open Label Study to Investigate the Tolerability and Efficacy of Oxcarbazepine in The Prophylaxis of Migraine Headache. Headache May 2004; (F76) 495.
30. Silberstein SD, Freitag FG, Rozen TD, Kudrow DB, Hewitt DJ, Jordan DM, Fisher AC, Rosenthal NR. Tramadol HCI/Acetaminophen Versus Placebo in The Treatment of Acute Migraine Pain. Headache May 2004; (OR18) 464.
31. Freitag FG, Houlihan J, Wu S. Early Onset of Response Observed for Topiramate When Used as A Migraine Preventive Agent. Headache May 2004; (S170) 528.
32. Rothrock JF, Freitag FG, Giargiari TD, Batey SR, Ludington EA. Safety and Efficacy of Zonisamide Versus Placebo in The Prophylaxis of Migraine Headache. Headache May 2004; (S174) 529.
33. Goldstein J, Silberstein SD, Elkind AH, Freitag FG, Gallagher RM, et al. A Placebo-Controlled Comparison of The Combination of Acetaminophen, Aspirin, And Caffeine with Sumatriptan Succinate in The Early Treatment of Migraine: Results from The Asset Trial. Neurology March 2003; 60(5)1: S22.005.
34. Diamond S, Freitag FG, Diamond ML, Urban GJ. Characterizing the Response Factors of IV Histamine as Adjunctive Therapy in Chronic Cluster Headache with Comparison to IV DHE As Adjunctive Therapy or Medical Therapy Alone. Cephalalgia May 2001; 21:501-502.
35. Freitag FG, Diamond S, Diamond ML, Urban GJ. Preventative Treatment of Migraine Headache with Rofecoxib And Montelukast. Cephalalgia May 2001; 21:375-376.
36. Freitag FG, Diamond S, Lockhart E. Topical Lidocaine in Migraine. Abstracts from 2001 Annual Meeting of American Society for Clinical Pharmacology and Therapeutics, Clinical Pharmacology & Therapeutics February 2001, 69:2.
37. Freitag FG, Diamond S, Diamond ML, Urban GJ. MIDAS as A Healthcare Utilization Predictor in Tertiary Cares Headache Management. Neurology 2001; 56(3):A311-312.
38. Edmeads J, Lainez JM, Brandes JL, Schoenen J, Freitag FG. Potential of The Migraine Disability Assessment (MIDAS) Questionnaire as A Public Health Initiative and In Clinical Practice. Neurology 2001; 56(6 Suppl 1): S29-34.
39. Sang CN, Ramadan NM, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Tepper SJ. A Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Tolerability Of 1.2mg/kg Intravenous LY293558 Versus 6mg Subcutaneous Sumatriptan Versus Placebo in Patients with An Acute Migraine Attack. Neurology 2001; 56(3): A218.
40. Diamond S, Freitag FG, Diamond ML, Urban GJ, Pepper BJ. Tizanidine In the Preventative Treatment of Chronic Tension-Type Headache. Cephalalgia May, 2000; 20:4.
41. Freitag FG, Diamond S, Lyss H, Diamond ML, Urban GJ, Pepper BJ. MIDAS as A Healthcare Utilization Tool in The Challenging Patient. Cephalalgia May, 2000; 20:4.
42. Freitag FG, Diamond S, Diamond ML, Urban GJ, Pepper BJ. Preventative Treatment of Chronic Cluster Headache with Divalproex Sodium. Cephalalgia May, 2000; 20:4
43. Wolf ME, Saavedra R, Hoang K, Freitag FG, Diamond S, Mosnaim AD. Leucine-Enkephalin Metabolism in Various Patient Populations: Drug Effects. Society of Biological Psychiatry, 55th Annual Convention and Scientific Program, May 11-13, 2000, Biological Psychiatry: A Journal of Psychiatric Neuroscience, April 15, 2000; 47:8S.
44. Freitag FG, Saper J, Winner P, Collins S. Depakote ER in Migraine Prophylaxis. Neurology. April, 2000; 54: A14-15.
45. Freitag FG, Diamond S, Diamond ML. Tiagabine in the Prophylaxis of Migraine. American Academy of Neurology, Neurology April 1999; 52 ;( 6) Sup 2: A208.
46. Diamond S, Freitag FG, Diamond ML, Urban GJ, Pepper BJ, Moore K. Treatment of Intractable Chronic Cluster Headaches: IV Histamine Desensitization. Headache May 1999; 39:5.
47. Freitag FG, Cady R, Elkind A. et al. Comparative Study of Midrin And Sumatriptan Succinate in The Treatment of Migraine Headache. Headache May 1999; 39:5.
48. Freitag FG, Diamond S, Diamond ML, Urban GJ, Pepper BJ, Moore K. Treatments in Migraine: First Year Clinical Experience. Headache May 1999; 39:5.
49. Freitag FG, Diamond S, Diamond ML, Urban GJ, Pepper BJ, Moore K. The Prophylaxis of Migraine with the Gaba-agonist, Tiagabine: A Clinical Report. Headache May 1999; 39:5.
50. Freitag FG, Diamond S, Bambhvani S. IV Histamine in Chronic Cluster Headaches. Clinical Pharmacology and Therapeutics. 1997; 61:141.
51. Diamond S, Urban GJ, Freitag FG, Diamond ML. Analysis of Patients with Cluster Headache. Cephalalgia 1997; 17:278.
52. Diamond S, Freitag FG, Balm TK, Berry DA. The Use of a Combination Agent of Ibuprofen and Caffeine in the Treatment of Episodic Tension-Type Headache. Cephalalgia 1997; 17:446.
53. Diamond S, Freitag FG, Bambhvani S. IV Histamine Desensitization Therapy in Recidivism: Chronic Cluster Headache Patients. Cephalalgia 1997; 17:457.
54. Diamond S, Freitag FG, Balm TK, Berry DA. Ibuprofen Plus Caffeine in the Treatment of Tension-Type Headache. Clinical Pharmacology and Therapeutics. 1997; 61:194.
55. Livingston SL, Diamond S, Freitag FG, Diamond ML. The Role of Prior Sexual and Physical Abuse on MMPI-2 Profiles in Women with Chronic Headache. International Association for the Study of Pain Press. Abstract presented in the 8th World Congress on Pain, August 17-22, 1996.
56. Diamond S, Freitag FG, Diamond ML, Urban GJ. IV Histamine Therapy in Intractable Cluster Headaches. Cephalalgia 1996; 16:358-359.
57. Diamond S, Freitag FG, Diamond, ML, Urban, GJ. Sumatriptan in Patients on MAOI'S. Clinical Pharmacology and Therapeutics. 1995; 57:202.
58. Freitag FG, Diamond S, Diamond ML. A Placebo Controlled Trial of Flunarizine in Migraine Prophylaxis. Cephalalgia. 1991; 11(suppl 11):157.
59. Mosnaim AD, Huprikar S, Wolf ME. Studies of Platelet Monoamine Oxidase Activity During an Acute Cluster Headache Attack. Cephalalgia. 1991; 11:254-255.
60. Diamond S, Freitag FG. Flunarizine in Migraine Therapy. Clinical Pharmacology and Therapeutics. 1990; 47:135.
61. Diamond S, Freitag FG. Analgesic Efficacy and Safety of TNB in the Acute Treatment of Migraine. Clinical Pharmacology and Therapeutics. 1990; 47:135.
62. Diamond S, Elkind A, Freitag FG, Gallagher RM, Moore K, Swerdlow B, Malkin S. Safety and Effectiveness of Cranial Electrotherapy in the Treatment of Tension Headache. Headache. 1989; 29:445-450.
63. Diamond S, Freitag FG. Tiosporone in Cluster Headache. Clinical Pharmacology and Therapeutics. 1989; 45:161.
64. Diamond S, Freitag FG, Gallagher RM. Tiospirone in the Treatment of Cluster Headache. Headache. 1989; 29:312.
65. Mosnaim AD, Ignacio R, Wolf ME, Freitag FG, Diamond S. MET Degradation in Headache Patients. Clinical Pharmacology and Therapeutics. 1989; 45:161.
66. Mosnaim AD, Ignacio R, Wolf ME, Freitag FG, Diamond S. Methionine-Enkephalin (MET) Degradation in Cluster Headache Patients. Cephalalgia. 1989; 9(10):104.
67. Diamond S, Freitag FG, Gallagher RM, Nursall A. The Effects of Weather on Migraine Frequency. Cephalalgia. 1989; 9(10):320.
68. Diamond S, Freitag FG, Gallagher RM, Chu G, Mosnaim AD. The Analgesic Efficacy of Transnasal Butorphanol (TNB) in the Acute Treatment of Migraine. Cephalalgia. 1989; 9(suppl 10):357.
69. Solomon GD, Freitag FG, Diamond S. Long term Use of MAO Inhibitors in the Management of Headache. Clinical Pharmacology and Therapeutics. 1988; 43:170.
70. Diamond S, Freitag FG, Solomon GD. Impact of Inpatient Headache Treatment on Subsequent Medical Care. Headache. 1988; 28:317.
71. Diamond S, Freitag FG, Solomon GD, Millstein E, Mehta N. Premonitory Symptoms in Migraine and Mixed Headaches. Headache. 1987; 27:286.
72. Kaplan R, Solomon GD, Diamond S, Freitag FG. The Role of MRI in the Evaluation of a Migraine Population: Preliminary Data. Headache. 1987; 27:286.
73. Solomon GD, Mehta N, Freitag FG, Diamond S. Verapamil in Refractory Headache Patients. Cephalalgia. 1987; 7(6):455-456.
74. Solomon GD, Diamond S, Freitag FG. Verapamil in Migraine Prophylaxis, Comparison of Dosages. Clinical Pharmacology and Therapeutics. 1987; 41:202.
75. Diamond S, Freitag FG, Robbins LD, Mehta N. Treatment of Headache with MAO Inhibitors. Headache. 1986; 26:313.
76. Diamond S, Freitag FG, Robbins LD, Mehta N. The Use of MAO Inhibitors and Tricyclic Antidepressants in the Treatment of Migraine and Mixed Headaches. Headache. 1986; 26:313.
77. Diamond S, Freitag FG, Robbins LD, Mehta N. Demographics of Cluster Headache Patients Attending an Outpatient Headache Clinic. Headache. 1986; 26:314.
78. Diamond S, Solomon GD, Freitag FG. Fenoprofen Calcium in Migraine Prophylaxis. Clinical Research 1987; 35:882.
79. Diamond S, Freitag FG, Prager J, Gandhi S. Treatment of Intractable Chronic Cluster Headache. Cephalalgia. 1985; 5:268-269.
80. Diamond S, Freitag FG, Maliszewski M, Prager J, Gandhi S. Treatment of Headache in the Inpatient Headache Unit: Long term Results. Cephalalgia. 1985; 5:440-441.
81. Diamond ML, Diamond S, Freitag FG, Vavra I. Abstract: Treatment of Tension-Type Headache with Bromfenac, BAC and Placebo. Neurology. 1998; 50(4): A378
82. Freitag FG. Tension-Type Headache and Its Treatment. JAOA. 1998; 98:4, S9.
83. RESEARCH GRANTS:
84. ALD403-CLIN-011. Alder BioPharmaceuticals, Inc. A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Phase 3 Trial to Evaluate the Efficacy, and Safety, of ALD403 Administered Intravenously in Patients with Chronic Migraine 2017
85. UBR-MD-01/UBR-MD-02 Allergan Pharmaceuticals. A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Single-Attack Study to Evaluate the Efficacy, Safety and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine. 2017
86. UBR-MD-04 Allergan Pharmaceuticals. A Multicenter, Randomized, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine with or Without Aura. 2017
87. MOTS. Migraine Overuse Treatment Strategy Trial. NINDS, 2016-2017
88. A Placebo-Controlled, Single-Blind Study Evaluating the Safety and Efficacy of Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia. PROTOCOL NO.: C402. 2016-2017.
89. Capnia, Inc.
90. Headache Medicine Fellowship at Froedtert and the Medical College of Wisconsin Grant. Allergan 2014- 2015
91. Headache Medicine Fellowship at Froedtert and the Medical College of Wisconsin Grant. Allergan 2013-2014.
92. COMPEL: a two-year open label study of onabotulinumtoxin A in the treatment of chronic migraine 2012-2013.
93. Amgen: AMG 334 20120178: a double blind, placebo controlled, randomized trial in the treatment of episodic migraine. 2013.
94. Sumatriptan RT/Naproxen Verses Naproxen in Treatment and Disease Modification of Migraine: A Pilot Study. 2010-2012.
95. Treatment of Chronic Migraine: A Three-Month Comparator Study of Naproxen Sodium vs. SumaRT/Nap. 2010-2012.
96. Improving Function by Targeting Function: Efficacy of an Interdisciplinary Outpatient Program. 2011-2012.
97. TXA107979: A Randomized, Multi-center, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of a Combination Product Containing Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents, 2010.
98. A dose-ranging study evaluating the efficacy, safety, and tolerability of GSK1838262 (XP13512) in the prophylactic treatment of migraine headache, 2010.
99. A Multi-Center, Open-label Evaluation of Treatment Satisfaction, Tolerability, Safety, and Preference for Sumavel DosePro for Treatment of Migraine in Subjects Dissatisfied with Their Existing Triptan Therapy, 2010
100. MAP0004: Long-Term Phase 3 Study. 2009-2010.
101. Nebivolol vs. Topiramate in Migraine Prevention, 2009- 2010
102. An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine over 12 Months, 2009-2010.
103. An observational, multi-center, parallel group Study [TRX112617] to evaluate the Impact of TREXIMET versus oral Triptan alone on work-related productivity loss due to migraine when administered during the mild, moderate, or severe phase of a migraine occurring prior to, or during, a scheduled work day, 2009 -2010.
104. Open-Label Trial of Frova 2.5mg Oral Tablets in Patients with Chronic Migraine, 2009- 2010
105. An Assessment of Migraineurs' Decision Making When Treating an Acute Migraine Headache, 2009
106. Assessment of the effect of sumatriptan and naproxen sodium combination tablet, sumatriptan tablet, and naproxen sodium tablet treatment on blood pressure when administered intermittently for six months for the acute treatment of migraine attacks, with or without aura, in adults (TXA 110948), 2009.
107. A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg for the Treatment of Acute Migraine in Sumatriptan Non-Responders, 2009.
108. The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study, 2009.
109. A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Efficacy and Safety Study of Staccato® Loxapine for Inhalation in Outpatients with Migraine Headache, 2009.
110. A Safety, Tolerability, and Efficacy Study of LY2590443 in the Treatment of Acute Migraine Headache, 2009.
111. A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled, Crossover Study to Evaluate the Safety and Efficacy of MK-0974 in the Treatment of Acute Migraine in Patients with Stable Vascular Disease, 2009.
112. A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Nasal Carbon Dioxide in the Treatment of Mild Headache in Migraineurs, 2009.
113. A Multi-Center, Double-Blind, Active-Controlled, Parallel Group Study to Examine the Safety, Tolerability and Efficacy of Oral MK-0974 for the Long-Term Treatment of Acute Migraine with or without Aura, 2009.
114. A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-3207 in the Treatment of Acute Migraine, 2009.
115. Chronic Migraine Treatment Trial (NINDS, NIH), 2008-2010
116. A Phase IIa, Multi-Center, Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of MK-0974 for Migraine Prophylaxis in Patients with Episodic Migraine, 2008.
117. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of MAP0004 in Adult Migraineurs for a Single Migraine Followed by Open-Label Extensions to 26/52 Weeks (FREEDOM301 Trial), 2008.
118. A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of TREXIMA (Sumatriptan + Naproxen Sodium) versus Butalbital-containing Combination Medications (BCM) for the Acute Treatment of Migraine when administered during the Moderate-Severe Pain Phase of the Migraine (Study 1 of 2) TRX 109011, 2008.
119. A Multi-Center, Parallel-Group, Double-Blind, Placebo Controlled, Dose Ranging Study of the Efficacy and Tolerability of TEMPUS (Tonabersat Evaluation in Migraine Prevention in the US) Tonabersat in the Prophylaxis of Migraine Headache and Open Label Extension, 2007.
120. A Phase 3 Open-Label Study to Assess Subcutaneous Self-Injection with Sumatriptan Succinate Using the Sumavel Dosepro Auto-Injector During a Single Migraine Attack, 2007.
121. A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose, Efficacy and Safety Study of Staccato TM Loxapine For Inhalation in Patients with Migraine Headache, 2007.
122. A Multi-Center, Double-Blind, Active-Controlled, Parallel Group Study to Examine the Safety, Tolerability and Efficacy of Oral MK-0974 For the Long-Term Treatment of Acute Migraine with Or Without Aura, 2007.
123. A Multi-Center, Double-Blind, Placebo and Active-Controlled, Parallel Group Study to Compare the Efficacy and Safety of Oral MK-0974 With Placebo and Zolmitriptan For the Acute Treatment of Migraine with Or Without Aura, 2007.
124. A Multi-Center, Open-Label, Single-Dose, Single-Arm Study to Evaluate the Usability of Subcutaneously Administered Sumatriptan Delivered Via the Intraject® System in Adult Patients During Acute Migraine Attack, 2007.
125. 4mg StatDose Sumatriptan in Naïve Patients. 2007.
126. Open-Label Trial of Frovatriptan 2.5mg Oral Tablets in Subjects with High Frequency of Migraine. 2007
127. Usability of the Sumatriptan DosePro Needle-Free System in Adult Migraineurs during Acute Migraine Attack outside of the Clinic. 2006-2007
128. The PRISM Study (Precision Implantable Stimulator for Migraine): Occipital Nerve Stimulation (ONS) for Migraine, 2006- 2010.
129. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Elimination of Migraine-Associated Nausea in Migraine Patients Treated with Rizatriptan Orally Disintegrating Tablet (ODT), 2006.
130. TRX 103632. A Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Cross-over Study to Determine the Consistency of Response for Treximet (Sumatriptan 85mg/Naproxen sodium 500mg) Administered During the Mild Pain Phase for the Acute Treatment of Multiple Migraine Attacks, 2006.
131. A Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Safety, Tolerance and Efficacy of a Single subcutaneous Dose of Tezampanel in Patients with Acute Migraine, 2006.
132. DHC-07 - 4mg Stat Dose Imitrex for Acute Treatment of Cluster Headache, 2006.
133. A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose, Efficacy and Safety Outpatient Study of StaccatoTM Prochlorperazine for Inhalation in Patients with Migraine Headache, 2006.
134. A Phase III Randomized, Double-Blind, Parallel Group, Sham-Controlled Study Evaluating the Efficacy and Safety of Non-Invasive, Non-Repetitive Transcranial TMS Stimulation (TMS) for the Acute Preemptive Treatment of The Aura Phase of Migraine Headache, 2006.
135. TRX107562 - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Tolerability of TREXIMATM (Sumatriptan Succinate/Naproxen Sodium) For A Single Moderate or Severe Headache in Adults Diagnosed with Probable Migraine Without Aura, 2006.
136. Disease Severity and Economic Impact of Headache in a Tertiary Headache Treatment Center. 2005-2007
137. DHC-09. Maxalt 10mg Plus Caffeine 75mg In the Acute Treatment of Migraine 2006.
138. Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan with Acetaminophen for the Acute Treatment of Migraine. 2006
139. Randomized, Double-Blind, Place-Controlled Trial of Topiramate in Chronic Migraine 2006.
140. IRUSZOLM0025 - Patient's decisions to treat migraine-influencing effects on Zomig Efficacy, 2005.
141. CAPSS 276 - A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Chronic Migraine, 2005.
142. CAPSS 295 - An Open-Label Study of the Safety and Efficacy of Topiramate for the Prophylaxis of Chronic Migraine, 2005.
143. A Multi-Center Study Evaluating the Efficacy and Safety of Botox® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients With 15 Or More Headache Days Per 4-Week Period in A 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed by A 32-Week Open-Label Extension Phase, 2005.
144. Long-Term, Open-Label Safety Study of Oral Almotriptan Malate 12.5mg in the Treatment of Migraine in Adolescents, 2005.
145. Topiramate Intervention to Prevent Transformation of EPIsoDic Migraine: The Topiramate INTREPID Study, 2005.
146. A Randomized, Double-Blind, Single-Dose, Placebo-Controlled Evaluation of the Safety and Efficacy of Intravenous Lornoxicam in the Acute Treatment of Headache of Migraine, 2005.
147. DHC-05 - Open-Label Trial of Frova 2.5mg Oral Tablets in Patients with High Frequency of Migraine (w/ and w/out aura) Previously Treated with Triptan, 2005.
148. Efficacy of AXERT® (Almotriptan Malate) in the Acute Treatment of Migraine: A Pilot Study of the Potential Impact of Preventive Therapy with TOPAMAX® (Topiramate), 2005.
149. Program to Assess Headache Treatment Strategies: Baseline and Preliminary Results from an Observational Study of Botulinum Toxin Type A Prophylactic Headache Treatment. 2004- 2005
150. AIMS: AXERT 12.5mg Time versus Intensity Migraine Study. 2004.
151. Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache in Migraineurs: Effect on Acute Headache Pain Medication Use. 2004.
152. A Pilot Study of Divalproex Sodium ER in Chronic Migraine without Medication Overuse Headache. 2004
153. A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Single Attack Evaluation of The Efficacy and Tolerability of Treximet (Sumatriptan 85mg/Naproxen Sodium 500mg) Tablets Versus Placebo When Administered During the Mild Phase of a Migraine, 2004-2005.
154. AXERT® Early miGraine Intervention Study (AEGIS): Efficacy and Safety of AXERT® (Almotriptan Malate) versus Placebo for the Acute Treatment of Migraine Headache, 2004-2005.
155. A Phase II, Multi-Center, Randomized, Double-Blind Study to Evaluate the Dose-Related Efficacy and Safety of CAP3 in the Treatment of Acute Migraines (ESCAPE), 2004-2005.
156. An Open-Label, Repeat Dose Study of the Safety of Combo Formulation in the Treatment of Multiple Episodes of Acute Migraine Over 12 Months, 2004-2005.
157. An Open-Label Study of the Safety and Efficacy of Topiramate for the Prophylaxis of Chronic Migraine: Extension Study to CAPSS-276, 2004-2005.
158. CAPSS 334 - Efficacy of AXERT in the Acute Treatment of Migraine: A Pilot Study of the Potential Impact of Preventive Therapy with TOPAMAX, 2004.
159. A Multi-center, Randomized, Double-Blind, Parallel-Group, Placebo Controlled, Efficacy, Safety and Tolerability Study of Dronabinol MDI in Acute Treatment of Migraine Headache, 2004.
160. A Phase II Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches, 2004.
161. A Multi-Center, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10mg Tablets Administered Early During a Migraine Attack While the Pain is Mild, 2004.
162. A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Single Dose Study to Evaluate the Safety and Efficacy of Treximet in the Acute Treatment of Migraine Headaches, 2004.
163. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Study to Evaluate the Onset of Efficacy of a New Formulation of Sumatriptan Tablets 50mg and 100mg in the Acute Treatment of Migraine, 2004.
164. Stat Dose Imitrex as Therapy for Acute Migraine in Patient Who Fail to Respond to Oral Triptans, 2003-2004.
165. A Randomized, double-Blind, Placebo Controlled, Parallel Group, Dose-Ranging, Multicenter Study of the Efficacy of RWJ-333369 in the Prophylaxis of Migraine, 2004.
166. CAPSS 316 - AXERT Early Migraine Intervention Study (AEGIS) Efficacy and Safety of AXERT (Almotriptan Malate) versus Placebo for the Acute Treatment of Migraine Headache, 2004.
167. Tramadol HCI/Acetaminophen Versus Placebo in The Treatment of Acute Migraine Pain. 2004.
168. Subject's Decisions to Treat Migraine: Influencing Effects on Zomig Efficacy, 2004.
169. An Open-Label, Multi-Center, One-Year Extension of the Evaluation of the Efficacy and Safety of Donepezil Hydrochloride (E2020) in Migraine Prophylaxis, 2003-2004.
170. A Comparison of the Efficacy and Safety of Topiramate vs. Placebo for Prophylaxis of Chronic Migraine, 2003-2004.
171. Treatment of Migraine in Patients Who Historically Fail to Respond to Oral Triptans. Results with Sumatriptan Subcutaneous. 2003.
172. Does Sumatriptan 6mg Subcutaneous Override the Effects of Allodynia on Acute Migraine Outcome? 2003.
173. Multi-Center, Randomized Double Blind Study to Evaluate the Dose-Related Efficacy and Safety of
174. CAP3 in the Treatment of Acute Migraine (ESCAPE), 2003.
175. A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of Multiple Treatments of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Prophylactic Treatment of Headaches in the Chronic Headache Population, 2003.
176. A Multicenter Study Evaluating the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 or More Headache Days per 4-Week Period in a 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed by a 32-Week Open Label Extension Phase.
177. A 20-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Preliminary Study to Evaluate the Efficacy and Safety of Two Fixed Doses (5mg and 10mg) of Donepezil Hydrochloride (E2020) in Migraine Prophylaxis, 2003.
178. A Placebo-Controlled Comparison of The Combination of Acetaminophen, Aspirin, And Caffeine with Sumatriptan Succinate in The Early Treatment of Migraine. 2003.
179. A Comparison of the Efficacy and Safety of ULTRACET™ (Tramadol HCL/Acetaminophen) Versus Placebo for the Acute Treatment of Migraine Headache Pain, 2003.
180. A Double-Blind, Randomized, Multi-Center, Parallel Dose Study to Evaluate the Safety and Efficacy of Zonisamide 150mg and 300mg per Day and Placebo in Subjects with Migraine Headache, 2003.
181. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Tolerability of Oral Sumatriptan 25mg, 50mg, and 100mg Tablets for a Single Moderate or Severe Headache in Adults Diagnosed with Migrainous Disorder (IHS 1.7), 2003.
182. Trileptal in the Treatment of Migraine Headache, 2003.
183. A Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Two Dose Levels (5mg and 20mg) of Sumatriptan Nasal Spray in the Acute Treatment of a Single Migraine Attack in Adolescent Migraineurs (12-17 years of age), 2003.
184. The Economic Impact of Treating in the Workplace with Rizatriptan when Migraine Pain is Mild, 2003.
185. A Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of MT-100 in the Early Treatment of Headache in Subjects with Migraine, 2003.
186. A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine, 2003.
187. A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Eletriptan (20 and 40mg) Versus Placebo in Early Treatment of Migraine, 2003.
188. Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Center Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache, 2002-2003.
189. The American Migraine Prevalence and Prevention (AMPP) Study. 2003-2010.
190. Program to Assess Treatment Strategies: A BOTOX Observational Program, 2003-2005.
191. TRX 106571. A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) In Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans. 2002
192. Botulinum Toxin Type A in the Treatment of Chronic Migraine with Medication Overuse Headache. 2002-2004
193. Depakote ER in the Treatment of Chronic Migraine, 2002-2004.
194. A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Trial to Evaluate Early Efficacy and Tolerability of Zolmitriptan (ZOMIG®) Nasal Spray in the Acute Treatment of Adult Subjects with Migraine, 2002.
195. A Multi-Center, Double-Blind, Placebo-Controlled, Randomized Trial and an Open-Label, Long-Term Tolerability Trial of Zolmitriptan (ZOMIG®) for the Acute Treatment of Migraine Headaches in Adolescent Subjects, 2002.
196. A Multi-Center, 2-Phase, Double-Blind, Randomized, Placebo-Controlled, Parallel Trial to Evaluate the Efficacy of a Single Dose of Zolmitriptan (ZOMIG®) as Acute Treatment in Phase I and Repeated Doses as Preemptive Treatment in Phase II for Menstrual Migraine Headache, 2002.
197. A Randomized Trial of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis. 2002.
198. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered during the Mild Pain Phase of a Menstrually-Associated Migraine Attack, 2002
199. A Comparison of the Efficacy and Safety of BOTOX vs. Placebo for the Prophylaxis of Migraine Headache, 2001-2005.
200. Characterizing the Response Factors of IV Histamine as Adjunctive Therapy in Chronic Cluster Headache with Comparison to IV DHE As Adjunctive Therapy or Medical Therapy Alone. 2001.
201. Preventative Treatment of Migraine Headache with Rofecoxib And Montelukast. 2001.
202. Topical Lidocaine in Migraine. 2001.
203. MIDAS as A Healthcare Utilization Predictor in Tertiary Cares Headache Management. 2001.
204. Potential of The Migraine Disability Assessment (MIDAS) Questionnaire as A Public Health Initiative and In Clinical Practice. 2001.
205. Comparative Study of a Combination of Isometheptene Mucate, Dichloralphenazone With Acetaminophen and Sumatriptan Succinate in The Treatment of Migraine. 2001.
206. A Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Tolerability Of 1.2mg/kg Intravenous LY293558 Versus 6mg Subcutaneous Sumatriptan Versus Placebo in Patients with An Acute Migraine Attack. 2001.
207. Leucine-Enkephalin Metabolism in Various Patient Populations: Drug Effects. 2000.
208. Depakote ER in Migraine Prophylaxis. 2000.
209. Degradation Kinetics of Leucine - Enkephalin By Plasma Samples from Healthy Controls and Various Patient Populations. May 2000.
210. Ibuprofen Plus Caffeine in The Treatment of Tension-Type Headache. 2000.
211. Intranasal Civamide For the Acute Treatment of Migraine Headache. 2000.
212. Flow Cytometric Analysis of Lymphocyte Subsets in Migraine Patients During and Outside of An Acute Headache Attack. 1998.
213. Bromfenac, BAC and Placebo in Tension-Type Headaches. 1998.
214. Subcutaneous Dihydroergotamine Mesylate (DHE) In the Treatment of Menstrual Migraine. 1996.
215. Apparent Lack of Correlation Between Tyramine and Phenylethylamine Content and Occurrence of Food-Precipitated Migraine. 1996.
216. Migraine and Cluster Headache Patients Are Characterized by Significant Alterations in Platelet Monoamine Oxidase Activity. 1996.
217. A Placebo Controlled Trial of Flunarizine in Migraine Prophylaxis. 1991.
218. Studies of Platelet Monoamine Oxidase Activity in Female Migraineurs 1991.
219. Studies of Platelet Monoamine Oxidase Activity During an Acute Cluster Headache Attack. 1991.
220. Transnasal Butorphanol (TNB) in the Acute Treatment of Migraine: A Placebo-Controlled Comparative Study Versus Intramuscular Methadone. 1991.
221. Plasma Degradation of Methionine-Enkephalin By Cluster Headache Patients (In Vitro Studies). 1990.
222. Analgesic Efficacy and Safety of TNB in the Acute Treatment of Migraine. 1990.
223. Safety and Effectiveness of Cranial Electrotherapy in the Treatment of Tension Headache. 1989.
224. Tiospirone in Cluster Headache. 1989.
225. Endogenous Opioid-Like Peptides in Headache. 1989.
226. MET Degradation in Headache Patients. 1989.
227. The Effects of Weather on Migraine Frequency. 1989.
228. Long-Acting Propranolol in The Prophylaxis of Migraine. 1987.
229. Fenoprofen In the Prophylaxis of Migraine: A Double-Blind, Placebo-Controlled Study. 1987.
230. Plasma and Platelet Methionine-Enkephalin Levels in Chronic Cluster Patients During an Acute Headache Episode. 1987.
231. Cold as An Adjunctive Therapy for Headache. 1986.
232. Plasma Methionine-Enkephalin. Increased Levels During a Migraine Episode. 1986.
233. Nadolol And Placebo Comparison Study in The Prophylactic Treatment of Migraine. 1984.
 

jenkins-FCD Prod-332 f92a19b0ec5e8e1eff783fac390ec127e367c2b5